Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2003 Jan 29;15(8):1513–1556. doi: 10.1016/0196-9781(94)90131-7

Endogenous opiates: 1993

Gayle A Olson ∗,a,1, Richard D Olson ∗,a, Abba J Kastin ∗,a,†
PMCID: PMC7124241  PMID: 7700854

Abstract

This paper is the sixteenth installment of our annual review of research concerning the opiate system. It is restricted to papers published during 1993 that concern the behavioral effects of the endogenous opiate peptides, and does not include papers dealing only with their analgesic properties. The specific topics this year include stress; tolerance and dependence; eating; drinking; gastrointestinal, renal, and hepatic function; mental illness and mood; learning, memory, and reward; cardiovascular responses; respiration and thermoregulation; seizures and other neurological disorders; electrical-related activity; general activity and locomotion; development; immunological responses; and other behaviors.

Keywords: Stress, Tolerance, Dependence, Eating, Drinking, Alcohol, Depression, Learning, Memory, Cardiovascular responses, Temperature, Respiration, Epilepsy, Activity, Mental illness, Aggression, Development, Immunology, Opiate, Peptide

References

  • 1.Abrahamsen G.C., Stock H.S., Calderone B.J., Schutz A.D., Rosellini R.A. Conditioned fear exacerbates acute precipitation of the morphine withdrawal syndrome. Soc. Neurosci. Abstr. 1993;19:370. [Google Scholar]
  • 2.Aceto M.D., Scates S.M., Ji Z., Bowman E.R. Nicotine's opioid and anti-opioid interactions: Proposed role in smoking behavior. Eur. J. Pharmacol. 1993;248:333–335. doi: 10.1016/0926-6917(93)90009-f. [DOI] [PubMed] [Google Scholar]
  • 3.Ackerman J.M., Moises H.M. Withdrawal from chronic morphine treatment produces alterations in the beta-adrenergic receptor-coupled adenylate cyclase system. Soc. Neurosci. Abstr. 1993;19:1248. [Google Scholar]
  • 4.Acquas E., Meloni M., Di Chiara G. Blockade of δ-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur. J. Pharmacol. 1993;230:239–241. doi: 10.1016/0014-2999(93)90809-v. [DOI] [PubMed] [Google Scholar]
  • 5.Aghajanian G.K., Kogan J.H., Moghaddam B. Increased glutamate release in the locus coeruleus (LC) during opiate withdrawal: A microdialysis study. Soc. Neurosci. Abstr. 1993;19:1247. [Google Scholar]
  • 6.Agmo A., Federman I., Navarro V., Padua M., Velazquez G. Reward and reinforcement produced by drinking water: Role of opioids and dopamine receptor subtypes. Pharmacol. Biochem. Behav. 1993;46:183–194. doi: 10.1016/0091-3057(93)90339-u. [DOI] [PubMed] [Google Scholar]
  • 7.Ahmed M.S., Cemerikic B., Mou S., Agbas A. Effects of methadone use during pregnancy on human placental opioid receptors. Membr. Biochem. 1993;10:91–98. doi: 10.3109/09687689309150256. [DOI] [PubMed] [Google Scholar]
  • 8.Akaoka H., Aston-Jones G. Indirect serotonergic agonists attenuate neuronal opiate withdrawal. Neuroscience. 1993;54:561–565. doi: 10.1016/0306-4522(93)90227-7. [DOI] [PubMed] [Google Scholar]
  • 9.Akil H. Molecular and integrative mechanisms of stress responsiveness: Implications for studying affective disorders. Neurobiology of affective disorders (Third annual Bristol-Myers Squibb Symposium on neuroscience research; October 25–26, 1991, Yale University School of Medicine; New York: Raven Health Care Communications; 1993. pp. 51–58. [Google Scholar]
  • 10.Akil H., Haskett R.F., Young E.A. Multiple HPA profiles in endogenous depression: Effect of age and sex on cortisol and beta-endorphin. Biol. Psychiatry. 1993;33:73–85. doi: 10.1016/0006-3223(93)90305-w. [DOI] [PubMed] [Google Scholar]
  • 11.Akin M.Z., Tuncel N., Burer F., Kural N., Uslu S. Effect of vasoactive intestinal peptide and naloxone combination on urinary N-acetyl-β-D-glucosaminidase level and kidney histology of rats exposed to severe hemorrhage. Pharmacology. 1993;47:194–199. doi: 10.1159/000139097. [DOI] [PubMed] [Google Scholar]
  • 12.Akiyama Y., Nishimura M., Kosayashi S. Effects of naloxone on the sensation of dyspnea during acute respiratory stress in normal adults. J. Appl. Physiol. 1993;74:590–595. doi: 10.1152/jappl.1993.74.2.590. [DOI] [PubMed] [Google Scholar]
  • 13.Alavi F.K., McCann J.P., Mauromoustakis A., Sangiah S. Feeding behavior and its responsiveness to naloxone differ in lean and obese sheep. Physiol. Behav. 1993;53:317–323. doi: 10.1016/0031-9384(93)90211-w. [DOI] [PubMed] [Google Scholar]
  • 14.Alcaraz C., Milanes M.V., Vargas M.L. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level. J. Pharmacol. Exp. Ther. 1993;266:1385–1389. [PubMed] [Google Scholar]
  • 15.Alcaraz C., Vargas M.L., Fuente T., Milanes M.V. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level. J. Pharmacol. Exp. Ther. 1993;266:1602–1606. [PubMed] [Google Scholar]
  • 16.Alesdatter J.E., Kalivas P.W. Inhibition of mu opioid-induced motor activity in the ventral pallidum by D1 receptor blockade. Behav. Pharmacol. 1993;4:645–651. [PubMed] [Google Scholar]
  • 17.Alreja M., Aghajanian G.K. Opiates suppress a resting sodium-dependent inward current and activate an outward potassium current in locus coeruleus neurons. J. Neurosci. 1993;13:3525–3532. doi: 10.1523/JNEUROSCI.13-08-03525.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Amoscato A.A., Spiess R.R., Sansoni S.B., Herberman R.B., Chambers W.H. Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases. Brain Behav. Immun. 1993;7:176–187. doi: 10.1006/brbi.1993.1019. [DOI] [PubMed] [Google Scholar]
  • 19.Andersen S.L., Robinson S.R., Smotherman W.P. Ontogeny of the stretch response in the rat fetus: Kappa opioid involvement. Behav. Neurosci. 1993;107:370–376. doi: 10.1037//0735-7044.107.2.370. [DOI] [PubMed] [Google Scholar]
  • 20.Andersen S.L., Umphress S.M., Robinson S.R., Smotherman W.P., Ward K.M., Kehoe P. Modulation of dopamine binding in the fetal rat: Effects of milk and exogenous opioid manipulation. Pharmacol. Biochem. Behav. 1993;46:377–381. doi: 10.1016/0091-3057(93)90367-3. [DOI] [PubMed] [Google Scholar]
  • 21.Arakawa K., Akami T., Okamoto M., Akioka K., Nakai I., Oka T., Nagase H. Vol. 25. 1993. Immunosuppression by delta opioid receptor antagonist; pp. 738–740. (Transplant. Proc.). [PubMed] [Google Scholar]
  • 22.Aravich P.F., Rieg T.S., Ahmed I., Lauterio T.J. Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: Relationship to anorexia nervosa. Brain Res. 1993;612:180–189. doi: 10.1016/0006-8993(93)91659-g. [DOI] [PubMed] [Google Scholar]
  • 23.Armour J.A., Huang M.H., Smith F.M. Peptidergic modulation of in situ canine intrinsic cardiac neurons. Peptides. 1993;14:191–202. doi: 10.1016/0196-9781(93)90029-g. [DOI] [PubMed] [Google Scholar]
  • 24.Arnold H.M., Robinson S.R., Spear N.E., Smotherman W.P. Conditioned opioid activity in the rat fetus. Behav. Neurosci. 1993;107:963–969. doi: 10.1037//0735-7044.107.6.963. [DOI] [PubMed] [Google Scholar]
  • 25.Asleson G.S., Herman B.H., Lewis J.A. Comparison of cardiovascular and other physical side effects of acute and chronic administration of naltrexone in autistic children. Soc. Neurosci. Abstr. 1993;19:1785. doi: 10.1089/cap.1993.3.157. [DOI] [PubMed] [Google Scholar]
  • 26.Aurich J.E., Dobrinski I., Hoppen H.-O., Grunert E. Stimulation of release of β-endorphin and oxytocin by prostaglandin F2α in cattle at parturition. J. Reprod. Fertil. 1993;97:161–166. doi: 10.1530/jrf.0.0970161. [DOI] [PubMed] [Google Scholar]
  • 27.Badiani A., Stewart J. Enhancement of the prophagic but not of the antidipsogenic effect of U-50,488H after chronic amphetamine. Pharmacol. Biochem. Behav. 1993;44:77–86. doi: 10.1016/0091-3057(93)90283-y. [DOI] [PubMed] [Google Scholar]
  • 28.Bagnol D., Herbrecht F., Jule Y., Jarry T., Cupo A. Changes in enkephalin immunoreactivity of sympathetic ganglia and digestive tract of the cat after splanchnic nerve ligation. Regul. Pept. 1993;47:259–273. doi: 10.1016/0167-0115(93)90393-m. [DOI] [PubMed] [Google Scholar]
  • 29.Baguinov O., Sanders K.M. Regulation of neural responses in the canine pyloric sphincter by opioids. Br. J. Pharmacol. 1993;108:1024–1030. doi: 10.1111/j.1476-5381.1993.tb13500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bailey P.L., Rhondeau S., Schafer P.G. Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology. 1993;79:49–59. doi: 10.1097/00000542-199307000-00010. [DOI] [PubMed] [Google Scholar]
  • 31.Bakshi V.P., Kelley A.E. Feeding induced by opioid stimulation of the ventral striatum: Role of opiate receptor subtypes. J. Pharmacol. Exp. Ther. 1993;265:1253–1260. [PubMed] [Google Scholar]
  • 32.Bakshi V.P., Kelley A.E. Striatal regulation of morphine-induced hyperphagia: An anatomical mapping study. Psychopharmacology (Berlin) 1993;111:207–214. doi: 10.1007/BF02245525. [DOI] [PubMed] [Google Scholar]
  • 33.Baldwin H.A., Koob G.F. Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology. 1993;8:15–21. doi: 10.1038/npp.1993.3. [DOI] [PubMed] [Google Scholar]
  • 34.Bals-Kubik R., Ableitner A., Herz A., Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 1993;264:489–495. [PubMed] [Google Scholar]
  • 35.Banks W.A., Kastin A.J., Ehrensing C.A. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1. J. Neurosci. Res. 1993;35:690–695. doi: 10.1002/jnr.490350611. [DOI] [PubMed] [Google Scholar]
  • 36.Baraban S.C., Stornetta R.L., Guyenet P.G. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats. J. Pharmacol. Exp. Ther. 1993;265:89–95. [PubMed] [Google Scholar]
  • 37.Barg J., Belcheva M., Rowinski J. Opioid receptor density changes in Alzheimer amygdala and putamen. Brain Res. 1993;632:209–215. doi: 10.1016/0006-8993(93)91155-l. [DOI] [PubMed] [Google Scholar]
  • 38.Barna I., Acs Z., Koenig J.I. Effects of hypnorm® (fentanyl) on ACTH/β-endorphin levels in plasma, pituitary and brain of 10-day-old rats. Life Sci. 1993;52:1417–1424. doi: 10.1016/0024-3205(93)90065-b. [DOI] [PubMed] [Google Scholar]
  • 39.Bartenstein P.A., Duncan J.S., Prevett M.C. Investigation of the opioid system in absence seizures with positron emission tomography. J. Neurol. Neurosurg. Psychiatry. 1993;56:1295–1302. doi: 10.1136/jnnp.56.12.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bauco P., Wang Y., Wise R.A. Lack of sensitization or tolerance to the facilitating effect of ventral tegmental area morphine on lateral hypothalamic brain stimulation reward. Brain Res. 1993;617:303–308. doi: 10.1016/0006-8993(93)91098-d. [DOI] [PubMed] [Google Scholar]
  • 41.Bauco P., Wise R.A. Intracranial self-stimulation during repeated morphine treatment and morphine withdrawal: A curve-shift analysis. Soc. Neurosci. Abstr. 1993;19:1246. [Google Scholar]
  • 42.Baumeister A.A., Hurry M., Curtis W., Chaney T.M., Wolf E., Leoni R.R. The antinociceptive and motivational effects of intranigral injection of opioid agonists. Neuropharmacology. 1993;32:1299–1303. doi: 10.1016/0028-3908(93)90024-w. [DOI] [PubMed] [Google Scholar]
  • 43.Baumeister A.A., Todd M.E., Sevin J.A. Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation. Clin. Neuropharmacol. 1993;16:271–294. doi: 10.1097/00002826-199308000-00001. [DOI] [PubMed] [Google Scholar]
  • 44.Beczkowska I.W., Koch J.E., Bostock M.E., Leibowitz S.F., Bodnar R.J. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res. 1993;618:261–270. doi: 10.1016/0006-8993(93)91274-v. [DOI] [PubMed] [Google Scholar]
  • 45.Bell I.R., Schwartz G.E., Peterson J.M., Amend D. Symptom and personality profiles of young adults from a college student population with self-reported illness from foods and chemicals. J. Am. Coll. Nutr. 1993;12:693–702. doi: 10.1080/07315724.1993.10718361. [DOI] [PubMed] [Google Scholar]
  • 46.Benjamin D., Grant E.R., Pohorecky L.A. Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. 1993;621:137–140. doi: 10.1016/0006-8993(93)90309-b. [DOI] [PubMed] [Google Scholar]
  • 47.Benouali S., Berard H., Roche M. Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats. Neuropeptides. 1993;24:299–305. doi: 10.1016/0143-4179(93)90019-7. [DOI] [PubMed] [Google Scholar]
  • 48.Bernatzky G., Panksepp J., Nelson E., Saba A. Modulation of opiate tolerance on social behaviors by MK-801. Soc. Neurosci. Abstr. 1993;19:1787. [Google Scholar]
  • 49.Bhargava H.N., Batwyshyn G.A., Reddy P.L., Veeranna Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat. Gen. Pharmacol. 1993;24:1351–1357. doi: 10.1016/0306-3623(93)90418-w. [DOI] [PubMed] [Google Scholar]
  • 50.Bhargava H.N., Matwyshyn G.A. Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology. 1993;47:344–350. doi: 10.1159/000139117. [DOI] [PubMed] [Google Scholar]
  • 51.Bhargava H.N., Matwyshyn G.A. Effect of NG-monomethyl-L-arginine on tolerance to U-50,488H in the rat. Soc. Neurosci. Abstr. 1993;19:1461. [Google Scholar]
  • 52.Bhargava H.N., Matwyshyn G.A., Rattan A.K., Koo K.L., Tejwani G.A. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1–13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res. 1993;600:151–155. doi: 10.1016/0006-8993(93)90413-h. [DOI] [PubMed] [Google Scholar]
  • 53.Bhargava H.M., Rahmani N.H. Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Pharmacology. 1993;46:75–81. doi: 10.1159/000139031. [DOI] [PubMed] [Google Scholar]
  • 54.Bhargava H.N., Thorat S.N. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice. Brain Res. 1993;625:120–124. doi: 10.1016/0006-8993(93)90144-c. [DOI] [PubMed] [Google Scholar]
  • 55.Bianchi M., Sacerdote P., Panerai A.E. CRH blockade reduces naloxone-reversible, but not naloxone nonreversible stress-induced analgesia. Soc. Neurosci. Abstr. 1993;19:1620. [Google Scholar]
  • 56.Bidzinska B., Petraglia F., Angioni S. Acetyl-L-carnitine effect on pituitary and plasma β-endorphin responsiveness to different chronic intermittent stressors. J. Neuroendocrinol. 1993;5:151–155. doi: 10.1111/j.1365-2826.1993.tb00375.x. [DOI] [PubMed] [Google Scholar]
  • 57.Bless E.P., Kelley A.E., Mahut H. Effects of opiate receptor blockade in the nucleus accumbens on feeding behavior. Soc. Neurosci. Abstr. 1993;19:1819. [Google Scholar]
  • 58.Borghese I.F., Herman B.H., Anselmi L.S. Effects of acutely and chronically administered naltrexone on social behavior and language of children with autism. Soc. Neurosci. Abstr. 1993;19:1785. [Google Scholar]
  • 59.Bormann N.M., Overton D.A. Decreasing morphine cue duration does not increase its effectiveness as a conditioned stimulus for fear. Soc. Neurosci. Abstr. 1993;19:370. [Google Scholar]
  • 60.Bowers R.L., Nicastle L.D., Falb D.C. Saccharin effects on morphine-induced temperature change in rats. Pharmacol. Biochem. Behav. 1993;46:483–485. doi: 10.1016/0091-3057(93)90384-6. [DOI] [PubMed] [Google Scholar]
  • 61.Bradley D.V., Blough P.M. Visual effects of opiates in pigeons: III. Luminance and wavelength sensitivity. Psychopharmacology (Berlin) 1993;111:117–122. doi: 10.1007/BF02257417. [DOI] [PubMed] [Google Scholar]
  • 62.Brambilla F., Ferrari E., Panerai A. Psychoimmunoendocrine investigation in anorexia nervosa. Neuropsychobiology. 1993;27:9–16. doi: 10.1159/000118947. [DOI] [PubMed] [Google Scholar]
  • 63.Brent P.J. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs. Neuropharmacology. 1993;32:751–760. doi: 10.1016/0028-3908(93)90183-4. [DOI] [PubMed] [Google Scholar]
  • 64.Brent P.J., Chahl L.A., Cantarella P.A., Kavanagh C. The κ-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs. Eur. J. Pharmacol. 1993;241:149–156. doi: 10.1016/0014-2999(93)90196-o. [DOI] [PubMed] [Google Scholar]
  • 65.Broad K.D., Kendrick K.M., Sirinathsinghji D.J.S., Keverne E.B. Changes in pro-opiomelanocortin and preproenkephalin mRNA levels in the ovine brain during pregnancy, parturition and lactation and in response to oestrogen and progesterone. J. Neuroendocrinol. 1993;5:711–719. doi: 10.1111/j.1365-2826.1993.tb00544.x. [DOI] [PubMed] [Google Scholar]
  • 66.Bronson M.E., Lin Y.-P., Burchett K., Picker M.J., Dykstra L.A. Serotonin involvement in the discriminative stimulus effects of κ opioids in pigeons. Psychopharmacology (Berlin) 1993;111:69–77. doi: 10.1007/BF02257409. [DOI] [PubMed] [Google Scholar]
  • 67.Bronstein D.M., Gutstein H.B., Akil H. Effects of chronic morphine treatment on β-endorphin-related peptides in the caudal medulla and spinal cord. J. Neurochem. 1993;60:2304–2307. doi: 10.1111/j.1471-4159.1993.tb03518.x. [DOI] [PubMed] [Google Scholar]
  • 68.Brooks D.P., Giardina G., Gellai M. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis. J. Pharmacol. Exp. Ther. 1993;266:164–171. [PubMed] [Google Scholar]
  • 69.Calabrese V.P., Gruemer H.D., Tripathi H.L., Dewey W., Fortner C.A., DeLorenzo R.J. Serum cortisol and cerebrospinal fluid β-endorphins in status epilepticus: Their possible relation to prognosis. Arch. Neurol. 1993;50:689–693. doi: 10.1001/archneur.1993.00540070009006. [DOI] [PubMed] [Google Scholar]
  • 70.Calignano A., Persico P., Mancuso F., Sorrentino L. Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur. J. Pharmacol. 1993;231:615–618. doi: 10.1016/0014-2999(93)90118-2. [DOI] [PubMed] [Google Scholar]
  • 71.Capogna M., Gahwiler B.H., Thompson S.M. Mechanism of μ-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. 1993;470:539–558. doi: 10.1113/jphysiol.1993.sp019874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Cappendijk S.L.T., de Vries R., Dzoljic M.R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 1993;62:97–100. doi: 10.1016/0304-3940(93)90569-7. [DOI] [PubMed] [Google Scholar]
  • 73.Carden S.E., Bortot A.T., Hofer M.A. Ultrasonic vocalizations are elicited from rat pups in the home cage by pentylenetetrazol and U50,488, but not naltrexone. Behav. Neurosci. 1993;107:851–859. doi: 10.1037//0735-7044.107.5.851. [DOI] [PubMed] [Google Scholar]
  • 74.Carr D.J.J., France C.P. Immune alternations in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Ther. 1993;267:9–15. [PubMed] [Google Scholar]
  • 75.Carr D.J.J., Gebhardt B.M., Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 1993;264:1179–1186. [PubMed] [Google Scholar]
  • 76.Carr K.D., Papadouka V., Wolinsky T.D. Norbinaltorphimine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation. Psychopharmacology (Berlin) 1993;111:345–350. doi: 10.1007/BF02244951. [DOI] [PubMed] [Google Scholar]
  • 77.Carr K.D., Wolinsky T.D. Chronic food restriction and weight loss produce opioid facilitation of perifornical hypothalamic self-stimulation. Brain Res. 1993;607:141–148. doi: 10.1016/0006-8993(93)91499-i. [DOI] [PubMed] [Google Scholar]
  • 78.Carter B.D., Medzihradsky F. Receptor mechanisms of opioid tolerance in SH-SY5y human neural cells. Mol. Pharmacol. 1993;43:465–473. [PubMed] [Google Scholar]
  • 79.Cestari V., Cabib S., Puglisi-Allegra S., Castellano C. The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors. Soc. Neurosci. Abstr. 1993;19:371. doi: 10.1016/s0163-1047(05)80069-x. [DOI] [PubMed] [Google Scholar]
  • 80.Chamouard P., Klein A., Martin E., Adloff M., Angel F. Regulatory role of enteric kappa opioid receptors in human colonic motility. Life Sci. 1993;53:1149–1156. doi: 10.1016/0024-3205(93)90551-d. [DOI] [PubMed] [Google Scholar]
  • 81.Chan E.-C., Smith R., Lewin T. Plasma corticotropin-releasing hormone, β-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol. (Copenh.) 1993;128:339–344. doi: 10.1530/acta.0.1280339. [DOI] [PubMed] [Google Scholar]
  • 82.Charness M.E., Hu G., Edwards R.H., Querimit L.A. Ethanol increases δ-opioid receptor gene expression in neuronal cell lines. Mol. Pharmacol. 1993;44:119–1127. [PubMed] [Google Scholar]
  • 83.Cheng P.Y., Wu D., Decena J., Soong Y., McCabe S., Szeto H.H. Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I. Eur. J. Pharmacol. 1993;230:85–88. doi: 10.1016/0014-2999(93)90413-c. [DOI] [PubMed] [Google Scholar]
  • 84.Cheng P.Y., Wu D., Soong Y., McCabe S., Decena J.A., Szeto H.H. Role of μ1 and δ-opioid receptors in modulation of fetal EEG and respiratory activity. Am. J. Physiol. 1993;265:R433–R438. doi: 10.1152/ajpregu.1993.265.2.R433. [DOI] [PubMed] [Google Scholar]
  • 85.Chiodera P., Volpi R., Maffei M.L. Role of GABA and opioids in the regulation of the vasopressin response to physical exercise in normal men. Regul. Pept. 1993;49:57–63. doi: 10.1016/0167-0115(93)90384-k. [DOI] [PubMed] [Google Scholar]
  • 86.Chrobak J.J., Napier T.C. Opioid and GABA modulation of accumbens-evoked ventral pallidal activity. J. Neural Transm. [Gen.] 1993;93:123–143. doi: 10.1007/BF01245342. [DOI] [PubMed] [Google Scholar]
  • 87.Chung H.D., Barg J., Belcheva M.M. Opioid receptor density changes in Alzheimer amygdala and putamen. Soc. Neurosci. Abstr. 1993;19:401. doi: 10.1016/0006-8993(93)91155-l. [DOI] [PubMed] [Google Scholar]
  • 88.Coda B.A., Hill H.F., Hunt E.B., Kerr E.B., Jacobson R.C., Chapman C.R. Cognitive and motor function impairments during continuous opioid analgesic infusions. Hum. Psychopharmacol. 1993;8:383–400. [Google Scholar]
  • 89.Colado M.I., Alfaro M.J., Lopez F., Del Val V., Martin M.I. Effect of nimodipine, diltiazem and BAY K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat: A comparison with clonidine. Gen. Pharmacol. 1993;24:35–41. doi: 10.1016/0306-3623(93)90008-l. [DOI] [PubMed] [Google Scholar]
  • 90.Collin E., Poulain P., Gauvain-Piquard A., Petit G., Pichard-Leandri E. Is disease progression the major factor in morphine “tolerance” in cancer pain treatment? Pain. 1993;55:319–326. doi: 10.1016/0304-3959(93)90007-C. [DOI] [PubMed] [Google Scholar]
  • 91.Colombo P.J., Rivera D.T., Martinez J.L., Jr., Bennett E.L., Rosenzweig M.R. Neurochemical and pharmacological examination of the involvement of [Met]enkephalin in memory for avoidance training in two regions of the chick brain. Soc. Neurosci. Abstr. 1993;19:370. [Google Scholar]
  • 92.Colombo P.J., Thompson K.R., Martinez J.L., Jr., Bennett E.L., Rosenzweig M.R. Dynorphin(1–13) impairs memory formation for aversive and appetitive learning in chicks. Peptides. 1993;14:1165–1170. doi: 10.1016/0196-9781(93)90171-c. [DOI] [PubMed] [Google Scholar]
  • 93.Comer S.D., Hoenicke E.M., Sable A.I. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J. Pharmacol. Exp. Ther. 1993;267:888–895. [PubMed] [Google Scholar]
  • 94.Comer S.D., McNutt R.W., Chang K.-J., De Costa B.R., Mosberg H.I., Woods J.H. Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors. J. Pharmacol. Exp. Ther. 1993;267:866–874. [PubMed] [Google Scholar]
  • 95.Cools A.R., Dierx J., Coenders C., Heeren D., Ried S., Jenks B.G., Ellenbroek B. Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in novelty-induced changes in hippocampal dynorphin B expression and two-way active avoidance: A new key in the search for the role of the hippocampal-accumbens axis. Behav. Brain Res. 1993;55:213–221. doi: 10.1016/0166-4328(93)90117-9. [DOI] [PubMed] [Google Scholar]
  • 96.Coons W.J., Vorhies R.W., Johnson T.C. Transferred T lymphocytes are compromised when the donor is pretreated with β-endorphin. J. Neuroimmunol. 1993;44:205–208. doi: 10.1016/0165-5728(93)90044-y. [DOI] [PubMed] [Google Scholar]
  • 97.Cooper E.L., Leung M.K., Suzuki M.M., Vick K., Cadet P., Stefano G.B. An enkephalin-like molecule in earthworm coelomic fluid modifies leukocyte behavior. Dev. Comp. Immunol. 1993;17:201–209. doi: 10.1016/0145-305x(93)90039-s. [DOI] [PubMed] [Google Scholar]
  • 98.Couceyro P., Douglass J.O. Immediate early gene induction in precipitating opiate withdrawal. Soc. Neurosci. Abstr. 1993;19:1246. [Google Scholar]
  • 99.Cruz S.L., Salazar L.A., Fernandex-Guasti A., Villarreal J.E. Quantitative analysis of concentration-response curves for precipitated abstinence responses in the opiate-dependent guinea pig ileum. J. Pharmacol. Exp. Ther. 1993;265:1519–1526. [PubMed] [Google Scholar]
  • 100.Cruz S.L., Villarreal J.E. Acute opioid dependence in the cardiovascular system of the spinal rat. J. Pharmacol. Exp. Ther. 1993;265:128–133. [PubMed] [Google Scholar]
  • 101.Csillag A., Stewart M.G., Szekely A.D., Magloczky Z., Bourne R.C., Steele R.J. Quantitative autoradiographic demonstration of changes in binding to delta opioid, but not mu or kappa receptors, in chick forebrain 30 minutes after passive avoidance training. Brain Res. 1993;613:96–105. doi: 10.1016/0006-8993(93)90459-z. [DOI] [PubMed] [Google Scholar]
  • 102.Cui Y., Lee T.F., Kramarova L.I., Wang L.C.H. The modulatory effects of mu and kappa opioid agonists on 5-HT release from hippocampal and hypothalamic slices of euthermic and hibernating ground squirrels. Life Sci. 1993;53:1957–1965. doi: 10.1016/0024-3205(93)90017-w. [DOI] [PubMed] [Google Scholar]
  • 103.D'Amore A., Marano G., Loizzo A. Reduced antinociceptive response to beta-endorphin in adult mice after chronic neonatal handling. Physiol. Behav. 1993;53:1025–1027. doi: 10.1016/0031-9384(93)90286-o. [DOI] [PubMed] [Google Scholar]
  • 104.Dawson-Basoa M.B., Gintzler A.R. 17 β-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res. 1993;601:241–245. doi: 10.1016/0006-8993(93)91716-6. [DOI] [PubMed] [Google Scholar]
  • 105.DeCabo D., Kitchen I., Kelly M., Viveros M.P. Effects of β-funaltrexamine treatment and sexual isolation in the perinatal period on the development of μ-opioid receptors and nociception. Psychoneuroendocrinology. 1993;18:415–424. doi: 10.1016/0306-4530(93)90016-e. [DOI] [PubMed] [Google Scholar]
  • 106.de-Castro R.M., Cabral-Filho J.E., Costa J.A., Costa F.B.R., Gallindo M.A.C., Hecksher C.A. Neonatal treatment with naloxone causes permanent hyperalgesia in rats. Brazil. J. Med. Biol. Res. 1993;26:747–751. [PubMed] [Google Scholar]
  • 107.Demitrack M.A., Putnma F.W., Rubinow D.R. Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: A pilot study. Psychiatry Res. 1993;49:1–10. doi: 10.1016/0165-1781(93)90026-d. [DOI] [PubMed] [Google Scholar]
  • 108.Depaulis A., Eichenlaub D., Lazarus C., Bandler R. A specific periaqueductal gray region mediates intraspecific defensive reactions evoked by precipitated morphine withdrawal. Soc. Neurosci. Abstr. 1993;19:1786. [Google Scholar]
  • 109.Deroche V., Piazza P.V., Casolini P., LeMoal M., Simon H. Sensitization of the psychomotor effects of amphetamine and morphine induced by food restriction depends on corticosterone secretion. Brain Res. 1993;611:352–356. doi: 10.1016/0006-8993(93)90526-s. [DOI] [PubMed] [Google Scholar]
  • 110.De Simoni M.G., De Luigi A., Gemma L., Sironi M., Manfridi A., Ghezzi P. Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 1993;265:R739–R742. doi: 10.1152/ajpregu.1993.265.4.R739. [DOI] [PubMed] [Google Scholar]
  • 111.Desmeules J.A., Kayser V., Gacel G., Guilbaud G., Roques B.P. The highly selective δ agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine. Brain Res. 1993;611:243–248. doi: 10.1016/0006-8993(93)90509-l. [DOI] [PubMed] [Google Scholar]
  • 112.Devinsky O., Emoto S., Nadi N.S., Theodore W.H. Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy. Epilepsia. 1993;34:255–261. doi: 10.1111/j.1528-1157.1993.tb02407.x. [DOI] [PubMed] [Google Scholar]
  • 113.De Vries T.J., Tjon Tien Ril G.H.K., Van der Laan J.W., Mulder A.H., Schoffelmeer A.N.M. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering μ-opioid receptor sensitivity. Life Sci. 1993;52:1685–1693. doi: 10.1016/0024-3205(93)90476-j. [DOI] [PubMed] [Google Scholar]
  • 114.de Waele J.-P., Gianoulakis C. Effects of single and repeated exposures to ethanol on hypothalamic β-endorphin and CRH release by the C57BL/6 and DBA/2 strains of mice. Neuroendocrinology. 1993;57:700–709. doi: 10.1159/000126428. [DOI] [PubMed] [Google Scholar]
  • 115.Dickson R., Zacharko R.M. Immediate and long term alterations induced by an acute stressor: Variations in activity, exploration and head dipping following intraventricular U50,488 administration. Soc. Neurosci. Abstr. 1993;19:1620. [Google Scholar]
  • 116.Ding X.Z., Bayer B.M. Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine. Brain Res. 1993;625:139–144. doi: 10.1016/0006-8993(93)90146-e. [DOI] [PubMed] [Google Scholar]
  • 117.Domanski E., Romanowica K., Kerdelhue B. Enhancing effect of intracerebrally infused β-endorphin antiserum on the secretion of cortisol in foot shocked sheep. Neuroendocrinology. 1993;57:127–131. doi: 10.1159/000126351. [DOI] [PubMed] [Google Scholar]
  • 118.Donahoe R.M. Neuroimmunomodulation by opiates: Relationship to HIV-1 infection and AIDS. Adv. Neuroimmunol. 1993;3:31–46. [Google Scholar]
  • 119.Dosaka-Akita K., Tortella F.C., Holaday J.W., Long J.B. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. J. Pharmacol. Exp. Ther. 1993;264:631–637. doi: 10.21236/ada263043. [DOI] [PubMed] [Google Scholar]
  • 120.Doudet D.J., Carson R.E., Channing M.A. Opiate receptor binding in the MPTP primate model of Parkinson's disease by PET. Soc. Neurosci. Abstr. 1993;19:631. [Google Scholar]
  • 121.Douglas A.J., Bicknell R.J. Oxytocin nerve terminal desensitization of κ-opioids at the end of pregnancy. Neurohypophysis: A window. Ann. NY Acad. Sci. 1993;689:589–592. doi: 10.1111/j.1749-6632.1993.tb55600.x. [DOI] [PubMed] [Google Scholar]
  • 122.Douglas A.J., Clarke G., MacMillan S.J.A. Effects of the κ-opioid agonist U50,488 on parturition in rats. Br. J. Pharmacol. 1993;109:251–258. doi: 10.1111/j.1476-5381.1993.tb13561.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Douglas A.J., Dye S., Leng G., Russell J.A., Bicknell R.J. Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat. J. Neuroendocrinol. 1993;5:307–314. doi: 10.1111/j.1365-2826.1993.tb00487.x. [DOI] [PubMed] [Google Scholar]
  • 124.Doyle T.G., Berridge K.C., Gosnell B.A. Morphine enhances hedonic taste palatability in rats. Pharmacol. Biochem. Behav. 1993;46:745–749. doi: 10.1016/0091-3057(93)90572-b. [DOI] [PubMed] [Google Scholar]
  • 125.Druhan J.P., Deschamps S-E., Stewart J. D-amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbens. Behav. Brain Res. 1993;59:41–51. doi: 10.1016/0166-4328(93)90150-o. [DOI] [PubMed] [Google Scholar]
  • 126.Durand S.E., Zuo M.X., Zhou S.L., Cheng M.-F. Avian auditory pathways show met-enkephalin-like immunoreactivity. Neuroreport. 1993;4:727–730. doi: 10.1097/00001756-199306000-00032. [DOI] [PubMed] [Google Scholar]
  • 127.Duvauchelle C.L., Fleming S.M., Kornetsky C. Vol. 19. 1993. Intra-accumbens DPDPE lowers the threshold for brain-stimulation reward; p. 1024. (Soc. Neurosci. Abstr.). [Google Scholar]
  • 128.Dyakonova T.L., Moroz L.L., Window W. Effects of met-enkephalin on electrical coupling between identified neurons in the pulmonate snails, Helix and Lymnaea. Comp. Biochem. Physiol. [C] 1993;106:93–101. doi: 10.1016/0742-8413(93)90259-n. [DOI] [PubMed] [Google Scholar]
  • 129.Dziki A.J., Lynch W.H., Ramsey C.B., Law W.R. β-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock. Circ. Shock. 1993;39:29–38. [PubMed] [Google Scholar]
  • 130.Eaton R., Rimanoczy A., Katay L., Vathy I. Effects of prenatal morphine on catecholamine turnover of adult male rats. Soc. Neurosci. Abstr. 1993;19:1249. [Google Scholar]
  • 131.Edvinsson L., Minthon L., Ekman R., Gustafson L. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration. Dementia. 1993;4:167–171. doi: 10.1159/000107318. [DOI] [PubMed] [Google Scholar]
  • 132.Eisenberg R.M., Forbes D.J. Naloxone-precipitated opioid withdrawal following chronic treatment with TRIMU-5, A μ2-opioid agonist. Soc. Neurosci. Abstr. 1993;19:1247. [Google Scholar]
  • 133.Ernst M., Devi L., Silva R.R. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacol. Bull. 1993;29:221–227. [PubMed] [Google Scholar]
  • 134.Etemadzadeh E. Cerebral catecholamine depletion in mice with-drawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion. J. Pharmacol. Exp. Ther. 1993;266:749–755. [PubMed] [Google Scholar]
  • 135.Ettenberg A., Geist T.D. Qualitative and quantitative differences in the operant runway behavior of rats working for cocaine and heroin reinforcement. Pharmacol. Biochem. Behav. 1993;44:191–198. doi: 10.1016/0091-3057(93)90298-8. [DOI] [PubMed] [Google Scholar]
  • 136.Everitt B.J., Schulteis G., Koob G.F. Attenuation of conditioned opiate withdrawal following excitotoxic lesions of the basolateral amygdala. Soc. Neurosci. Abstr. 1993;19:1246. [Google Scholar]
  • 137.Eyl C., Hakan R.L. Specific effects of morphine and nicotine on neuronal responses to ventral pallidum and fimbria stimulation in the nucleus accumbens. Soc. Neurosci. Abstr. 1993;19:1022. [Google Scholar]
  • 138.Faden A.I. Comparison of single and combination drug treatment strategies in experimental brain trauma. J. Neurotrauma. 1993;10:91–100. doi: 10.1089/neu.1993.10.91. [DOI] [PubMed] [Google Scholar]
  • 139.Fan L., McIntosh T.K. Cardiovascular effects of microinjection of dynorphin fragments into the nucleus of the solitary tract (NTS) are mediated by non-opioid mechanisms. Brain Res. 1993;623:110–116. doi: 10.1016/0006-8993(93)90017-h. [DOI] [PubMed] [Google Scholar]
  • 140.Fan L., McIntosh T.K. Regulation of the gene expression of preproenkephalin in the rat brain: Influence of hemorrhage. Circ. Shock. 1993;40:24–28. [PubMed] [Google Scholar]
  • 141.Fan L., Yeston N.S., McIntosh T.K. Effect of dynorphin microinjection in the anterior hypothalamus (AV3V) region on the hemodynamic response to hemorrhage in the rat. Circ. Shock. 1993;39:147–152. [PubMed] [Google Scholar]
  • 142.Fanselow M.S., DeCola J.P., Young S.L. Mechanisms responsible for reduced contextual conditioning with massed unsignaled unconditional stimuli. J. Exp. Psychol. [Anim. Behav.] 1993;19:121–137. [PubMed] [Google Scholar]
  • 143.Fantino M., Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiol. Behav. 1993;53:477–483. doi: 10.1016/0031-9384(93)90141-2. [DOI] [PubMed] [Google Scholar]
  • 144.Farabollini F., Albonetti M.E., Aloisi A.M. Immune and neuroendocrine response to restraint in male and female rats. Psychoneuroendocrinology. 1993;18:175–182. doi: 10.1016/0306-4530(93)90002-3. [DOI] [PubMed] [Google Scholar]
  • 145.Ferber C., Duclaux R., Mouret J. Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep. J. Sleep Res. 1993;2:149–155. doi: 10.1111/j.1365-2869.1993.tb00079.x. [DOI] [PubMed] [Google Scholar]
  • 146.Ferrari C.M., Melton P.M., Riley A.L. Conditioned taste aversions to compounds with opiate agonist/antagonist activity at specific opiate receptor subtypes. Soc. Neurosci. Abstr. 1993;19:1027. [Google Scholar]
  • 147.Fidler P., Kalman B.A., Ziemer H.E., Green K.F. Early onset of reduced morphine analgesia by ingestion of sweet solutions. Physiol. Behav. 1993;53:167–171. doi: 10.1016/0031-9384(93)90026-c. [DOI] [PubMed] [Google Scholar]
  • 148.Fillion C., Tahri-Joutei A., Allevard A.M. Local regulation of testicular immunoreactive-arginine vasopressin and steroidogenesis by naloxone. Biol. Reprod. 1993;48:793–797. doi: 10.1095/biolreprod48.4.793. [DOI] [PubMed] [Google Scholar]
  • 149.Fischer W., Bodewei R., Von Voigtlander P.F., Muller M. Anticonvulsant and related effects of U-54494A in various seizure tests. J. Pharmacol. Exp. Ther. 1993;267:163–170. [PubMed] [Google Scholar]
  • 150.Fletcher G.H., Chiappinelli V.A. The actions of the κ1 opioid agonist U-50,488 on presynaptic nerve terminals of the chick ciliary ganglion. Neuroscience. 1993;53:239–250. doi: 10.1016/0306-4522(93)90302-v. [DOI] [PubMed] [Google Scholar]
  • 151.Flood J.F., Morley J.E., La Reginna M. Age-related changes in the pharmacological improvement of retention in senescence accelerated mouse (SAM) Neurobiol. Aging. 1993;14:159–166. doi: 10.1016/0197-4580(93)90092-p. [DOI] [PubMed] [Google Scholar]
  • 152.Florez J., Hurle M.A. Opioids in respiration and vomiting. In: Herz A., editor. Vol. 104. Spring-Verlag; Berlin, Germany: 1993. pp. 263–292. (Handbook of experimental pharmacology). II Opioids II. [Google Scholar]
  • 153.Foley K.M. Changing concepts of tolerance to opioids: What the cancer patient has taught us. In: Chapman C.R., Foley K.M., editors. Current and emerging issues in cancer pain: Research and practice. Raven Press, Ltd; New York: 1993. pp. 331–350. [Google Scholar]
  • 154.Fontani G., Vergnani L., Salvadori S. Effect of deltorphin on behavior and hippocampal electrical activity in rabbits. Physiol. Behav. 1993;53:285–290. doi: 10.1016/0031-9384(93)90206-u. [DOI] [PubMed] [Google Scholar]
  • 155.Foo H., Westbrook R.F. Effects of ICV and IT naloxone and morphine on the acquisition and expression of conditioned hypoalgesia. Soc. Neurosci. Abstr. 1993;19:1786. [Google Scholar]
  • 156.Foss J.F., Bass A.S., Goldberg L.I. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. J. Clin. Pharmacol. 1993;33:747–751. doi: 10.1002/j.1552-4604.1993.tb05618.x. [DOI] [PubMed] [Google Scholar]
  • 157.France C.P., Woods J.H. U-50,488, saline and naltrexone discrimination in u-50,488-treated pigeons. Behav. Pharmacol. 1993;4:509–516. [PubMed] [Google Scholar]
  • 158.Franzen L., Forsgren S., Gustafsson H., Henriksson R. Irradiation-induced effects on the innervation of rat salivary glands: Changes in enkephalin- and bombesin-like immunoreactivity in ganglionic cells and intraglandular nerve fibers. Cell Tissue Res. 1993;271:529–536. doi: 10.1007/BF02913737. [DOI] [PubMed] [Google Scholar]
  • 159.Frost J.J. Receptor imaging by PET and SPECT: Focus on the opiate receptor. J. Recep. Res. 1993;13:39–53. doi: 10.3109/10799899309073644. [DOI] [PubMed] [Google Scholar]
  • 160.Frye C.A., Cuevas C.A., Kanarek R.B. Diet and estrous cycle influence pain sensitivity in rats. Pharmacol. Biochem. Behav. 1993;45:255–260. doi: 10.1016/0091-3057(93)90116-b. [DOI] [PubMed] [Google Scholar]
  • 161.Funada M., Narita M., Suzuki T., Misawa M. Effect of pretreatment with pertussis toxin on the development of physical dependence on morphine. Arch. Pharmacol. 1993;348:88–95. doi: 10.1007/BF00168542. [DOI] [PubMed] [Google Scholar]
  • 162.Funada M., Suzuki T., Narita M., Misawa M., Nagase H. Blockade of morphine reward through the activation of κopioid receptors in mice. Neuropharmacology. 1993;32:1315–1323. doi: 10.1016/0028-3908(93)90026-y. [DOI] [PubMed] [Google Scholar]
  • 163.Funada M., Suzuki T., Narita M., Misawa M., Nagase H. Modification of morphine-induced locomotor activity by pertussis toxin: Biochemical and behavioral studies in mice. Brain Res. 1993;619:163–172. doi: 10.1016/0006-8993(93)91608-u. [DOI] [PubMed] [Google Scholar]
  • 164.Fundytus M.E., Norris S., Coderre T.J. Excitatory amino acid (EAA) antagonists attenuate seizures induced by ICV morphine-3-glucuronide (M3G) Soc. Neurosci. Abstr. 1993;19:1787. [Google Scholar]
  • 165.Gabrilovac J. Leu-enkephalin modulates the migration inhibition of mouse splenocytes induced by cAMP-elevating agents. Int. J. Immunopharmacol. 1993;15:557–565. doi: 10.1016/0192-0561(93)90072-7. [DOI] [PubMed] [Google Scholar]
  • 166.Galea L.A.M., Kavaliers M., Innes D.L., Ossenkopp K.-P. Sex differences in opioid and nonopioid mediated swim-stress induced analgesia in dder mice vary with the breeding season. Soc. Neurosci. Abstr. 1993;19:170. [Google Scholar]
  • 167.Galizio M., Ordronneau C. Opioids and timeout from avoidance: Effects of fentanyl, methadone, and U50,488. Soc. Neurosci. Abstr. 1993;19:1786. [Google Scholar]
  • 168.Gallagher M., Nicolle M.M. Animal models of normal aging: Relationship between cognitive decline and markers in hippocampal circuitry. Behav. Brain Res. 1993;57:155–162. doi: 10.1016/0166-4328(93)90131-9. [DOI] [PubMed] [Google Scholar]
  • 169.Gallimberti L., Cibin M., Pagnin P. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 1993;9:77–81. doi: 10.1038/npp.1993.45. [DOI] [PubMed] [Google Scholar]
  • 170.Gamaleya N., Tagliaro F., Parshin A. Immune response to opiates: New findings in heroin addicts investigated by means of an original enzyme immunoassay and morphine determination in hair. Life Sci. 1993;53:99–105. doi: 10.1016/0024-3205(93)90656-n. [DOI] [PubMed] [Google Scholar]
  • 171.Ganesan R. Effect of morphine during pregnancy and lactation in mice. Pharmacol. Biochem. Behav. 1993;45:393–398. doi: 10.1016/0091-3057(93)90256-s. [DOI] [PubMed] [Google Scholar]
  • 173.Garza H.H., Jr., Stankov B., Fraschini F., Carr D.J.J. The relationship between opioids and melatonin in the immune system. Neuroendocrinol. Lett. 1993;1+2:135–148. [Google Scholar]
  • 172.Gauvin D.V., Moore K.R., Holloway F.A. Do rat strain differences in ethanol consumption reflect differences in ethanol sensitivity or the preparedness to learn? Alcohol. 1993;10:37–43. doi: 10.1016/0741-8329(93)90051-o. [DOI] [PubMed] [Google Scholar]
  • 174.Gavend M., Mallaret M., Caron F., Baragatti G. Antagonism of metergoline on the diuretic effect of cyclazocine and U-50488 drugs with a kappa agonist activity. Biomed. Pharmacother. 1993;47:337–344. doi: 10.1016/0753-3322(93)90083-w. [DOI] [PubMed] [Google Scholar]
  • 175.Ge F., Hammer R.P., Jr., Tobet S.A. Ontogeny of leu-enkephalin and β-endorphin innervation of the preoptic area in male and female rats. Dev. Brain Res. 1993;73:273–281. doi: 10.1016/0165-3806(93)90147-3. [DOI] [PubMed] [Google Scholar]
  • 176.Gillman M.A. Analgesic nitrous oxide should join the opioid family after almost two centuries. Suid-Afrikaanse Tydskrif vir Wetenskap. 1993;89:25–27. [Google Scholar]
  • 177.Gilmore W., Moradzadeh D.S. β-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM. J. Neuroimmunol. 1993;48:81–90. doi: 10.1016/0165-5728(93)90061-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Giraudo S.Q., Grace M.K., Welch C.C., Billington C.J., Levine A.S. Naloxone's anorectic effect is dependent upon the relative palatability of food. Pharmacol. Biochem. Behav. 1993;46:917–921. doi: 10.1016/0091-3057(93)90222-f. [DOI] [PubMed] [Google Scholar]
  • 179.Gispen-de Wied C.C., D'Haenen H., Verhoeven W.M.A. Inhibition of the pituitary-adrenal axis with dexamethasone and cortisol in depressed patients and healthy subjects: A dose-response study. Psychoneuroendocrinology. 1993;18:191–204. doi: 10.1016/0306-4530(93)90004-5. [DOI] [PubMed] [Google Scholar]
  • 180.Giuffra M., Mouradian M.M., Davis T.L., Ownby J., Chase T.N. Dynorphin agonist therapy of Parkinson's disease. Clin. Neuropharmacol. 1993;16:444–447. doi: 10.1097/00002826-199310000-00007. [DOI] [PubMed] [Google Scholar]
  • 181.Given M.B., Lowe R.F., Sander G.E., Giles T.D. Acute hypotension alters hemodynamic response to methionine-enkephalin in conscious dogs. Peptides. 1993;14:445–448. doi: 10.1016/0196-9781(93)90130-9. [DOI] [PubMed] [Google Scholar]
  • 182.Glamsta E.-L., Morkrid L., Lantz I., Nyberg F. Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and β-endorphin following long distance running. Regul. Pept. 1993;49:9–18. doi: 10.1016/0167-0115(93)90378-l. [DOI] [PubMed] [Google Scholar]
  • 183.Glickman-Weiss E.L., Nelson A.G., Hearon C.M., Goss F.L., Robertson R.J. Are beta-endorphins and thermoregulation during cold-water immersion related? Undersea Hypertens. Med. 1993;20:205–213. [PubMed] [Google Scholar]
  • 184.Goodwin G.A., Moody C.A., Spear L.P. Prenatal cocaine exposure increases the behavioral sensitivity of neonatal rat pups to ligands active at opiate receptors. Neurotoxicol. Teratol. 1993;15:425–431. doi: 10.1016/0892-0362(93)90060-2. [DOI] [PubMed] [Google Scholar]
  • 185.Gosnell B.A., Krahn D.D. Morphine-induced feeding: A comparison of the Lewis and Fischer 344 inbred rat strains. Pharmacol. Biochem. Behav. 1993;44:919–924. doi: 10.1016/0091-3057(93)90025-o. [DOI] [PubMed] [Google Scholar]
  • 186.Gosnell B.A., Krahn D.D. The effects of continuous morphine infusion on diet selection and body weight. Pharmacol. Biochem. Behav. 1993;54:853–859. doi: 10.1016/0031-9384(93)90292-n. [DOI] [PubMed] [Google Scholar]
  • 187.Gosnell B.A., Krahn D.D., Bell S.M., Lane K.E. Effects of diet composition and diet preference on pain sensitivity and morphine analgesia. Soc. Neurosci. Abstr. 1993;19:1819. [Google Scholar]
  • 188.Gosnell B.A., Patel C.K. Centrally administered μ- and δ-opioid agonists increase operant responding for saccharin. Pharmacol. Biochem. Behav. 1993;45:979–982. doi: 10.1016/0091-3057(93)90151-i. [DOI] [PubMed] [Google Scholar]
  • 189.Gouarderes C., Jhamandas K., Cridland R., Cros J., Quirions R., Zajac J.M. Opioid and substance P receptor adaptations in the rat spinal cord following subchronic intrathecal treatment with morphine and naloxone. Neuroscience. 1993;54:799–807. doi: 10.1016/0306-4522(93)90249-f. [DOI] [PubMed] [Google Scholar]
  • 190.Graham S.H., Shimizu H., Newman A., Weinstein P., Faden A.I. Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia. Brain Res. 1993;632:346–350. doi: 10.1016/0006-8993(93)91175-r. [DOI] [PubMed] [Google Scholar]
  • 191.Grant S.J., Sonti G. Antagonist action of buprenorphine on LC unit activity in morphine dependent rats. Soc. Neurosci. Abstr. 1993;19:1023. [Google Scholar]
  • 192.Grasing K., Szeto H. EEG changes with different levels of morphine self-administration. Neuropharmacology. 1993;32:543–553. doi: 10.1016/0028-3908(93)90050-d. [DOI] [PubMed] [Google Scholar]
  • 193.Grisel J.E., Fleshner M., Watkins L.R., Maier S.F. Opioid and nonopioid interactions in two forms of stress-induced analgesia. Pharmacol. Biochem. Behav. 1993;45:161–172. doi: 10.1016/0091-3057(93)90100-8. [DOI] [PubMed] [Google Scholar]
  • 194.Grisel J.E., Wiertelak E.P., Frohardt R.J., Yang H.-Y.T., Maier S.E., Watkins L.R. Conditioned tolerance in intravenous (iv) morphine: Demonstration and spinal mediation. Soc. Neurosci. Abstr. 1993;19:1025. [Google Scholar]
  • 195.Gudka B., Adeyemo M.O., Siren A.-L. Tolerance and withdrawal after intracerebroventricular infusion of the selective μ-opioid agonist Tyr-D-Arg2-Phe-(NME)GLY4 (TAPS) Soc. Neurosci. Abstr. 1993;19:1248. [Google Scholar]
  • 196.Guitart X., Kogan J.H., Berhow M., Terwilliger R.Z., Aghajanian G.K., Nestler E.J. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: Studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals. Brain Res. 1993;611:7–17. doi: 10.1016/0006-8993(93)91770-s. [DOI] [PubMed] [Google Scholar]
  • 197.Gulya K., Orpana A.K., Sikela J.M., Hoffman P.L. Prodynorphin and vasopressin mRNA levels are differentially affected by chronic ethanol ingestion in the mouse. Mol. Brain Res. 1993;20:1–8. doi: 10.1016/0169-328x(93)90105-x. [DOI] [PubMed] [Google Scholar]
  • 198.Gustafsson B.I., Delbro D.S. Motor effects of indomethacin, morphine or vagal nerve stimulation on the feline small intestine in vivo. Eur. J. Pharmacol. 1993;230:1–8. doi: 10.1016/0014-2999(93)90402-4. [DOI] [PubMed] [Google Scholar]
  • 199.Gustin T., Bachelot T., Verna J.-M.G. Immunodetection of endogenous opioid peptides in human brain tumors and associated cyst fluids. Cancer Res. 1993;53:4715–4719. [PubMed] [Google Scholar]
  • 200.Gutstein H.B., Trujillo K.A. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 1993;626:332–334. doi: 10.1016/0006-8993(93)90597-g. [DOI] [PubMed] [Google Scholar]
  • 201.Hagan M.M., Moss D.E. Effect of naloxone and antidepressants on hyperphagia produced by peptide YY. Pharmacol. Biochem. Behav. 1993;45:941–944. doi: 10.1016/0091-3057(93)90144-i. [DOI] [PubMed] [Google Scholar]
  • 202.Hamra J.G., Kamerling S.G., Wolfsheimer K.J., Bagwell C.A. Diurnal variation in plasma ir-beta-endorphin levels and experimental pain thresholds in the horse. Life Sci. 1993;53:121–129. doi: 10.1016/0024-3205(93)90659-q. [DOI] [PubMed] [Google Scholar]
  • 203.Haney M., Castanon N., Le Moal M., Mormede P. Social stress modulates morphine sensitivity in made and female Roman rats. Soc. Neurosci. Abstr. 1993;19:1619. [Google Scholar]
  • 204.Hansen S. Effect of clonidine on the responsiveness of infant rats to maternal stimuli. Psychopharmacology (Berlin) 1993;111:78–84. doi: 10.1007/BF02257410. [DOI] [PubMed] [Google Scholar]
  • 205.Harbuz M.S., Rees R.G., Lightman S.L. HPA axis responses to acute stress and adrenalectomy during adjuvant-induced arthritis in the rat. Am. J. Physiol. 1993;264:R179–R185. doi: 10.1152/ajpregu.1993.264.1.R179. [DOI] [PubMed] [Google Scholar]
  • 206.Harris A., Martin B.J. Effect of opiate and β-adrenergic blockers on the gut transit response to mild exercise. Int. J. Sports Med. 1993;14:320–323. doi: 10.1055/s-2007-1021185. [DOI] [PubMed] [Google Scholar]
  • 207.Harris G.C., Aston-Jones G. A role for accumbal D2 receptor activity in the initiation and prevention of the opiate withdrawal syndrome. Soc. Neurosci. Abstr. 1993;19:1247. [Google Scholar]
  • 208.Harris G.C., Aston-Jones G. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology. 1993;9:303–311. doi: 10.1038/npp.1993.66. [DOI] [PubMed] [Google Scholar]
  • 209.Harrison L.M., Zadina J.E., Banks W.A., Kastin A.J. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport. Dev. Brain Res. 1993;75:207–212. doi: 10.1016/0165-3806(93)90025-6. [DOI] [PubMed] [Google Scholar]
  • 210.Hayward N.J., McKnight A.T., Woodruff G.N. Neuroprotective effect of the κ-agonist enadoline (Cl-977) in rat models of focal cerebral ischaemia. Eur. J. Neurosci. 1993;5:961–967. doi: 10.1111/j.1460-9568.1993.tb00947.x. [DOI] [PubMed] [Google Scholar]
  • 211.He B., Chen C.-G. Possible involvement of atrial natriuretic factor and vasopressin in antihypertensive mechanism of clonidine in humans. Acta Pharmacol. Sinica. 1993;14:283–285. [PubMed] [Google Scholar]
  • 212.Hegbrant J., Thysell H., Martensson L., Ekman R., Boberg U. Changes in plasma levels of vasoactive peptides during sequential bicarbonate hemodialysis. Nephron. 1993;63:309–313. doi: 10.1159/000187215. [DOI] [PubMed] [Google Scholar]
  • 213.Hegrant J., Thysell H., Martensson L., Ekman R., Boberg U. Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis. Nephron. 1993;63:303–308. doi: 10.1159/000187214. [DOI] [PubMed] [Google Scholar]
  • 214.Heidbreder C.A., Goldberg S.R., Shippenberg T.S. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 1993;616:335–338. doi: 10.1016/0006-8993(93)90228-f. [DOI] [PubMed] [Google Scholar]
  • 215.Heitkamp H.-C., Schmid K., Scheib K. β-endorphin and adrenocorticotropic hormone production during marathon and incremental exercise. Eur. J. Appl. Physiol. 1993;66:269–274. doi: 10.1007/BF00235105. [DOI] [PubMed] [Google Scholar]
  • 216.Helton T.E., Daunais J.B., McGinty J.F. Convulsant doses of cocaine alter immediate early gene and opioid peptide expression in rat limbic forebrain. Mol. Brain Res. 1993;20:285–288. doi: 10.1016/0169-328x(93)90054-s. [DOI] [PubMed] [Google Scholar]
  • 217.Helton T.E., McGinty J.F. Intrahippocampal NMDA administration alters fos, fos-related antigens, and opioid peptide immunoreactivity and mRNA in rats. Mol. Cell. Neurosci. 1993;4:319–334. doi: 10.1006/mcne.1993.1042. [DOI] [PubMed] [Google Scholar]
  • 218.Herbert J., Howes S.R. Interactions between corticotropin-releasing factor and endogenous opiates on the cardioaccelerator, hypothermic, and corticoid responses to restraint in the rat. Peptides. 1993;14:145–152. doi: 10.1016/0196-9781(93)90022-9. [DOI] [PubMed] [Google Scholar]
  • 219.Herman B.J., Asleson G., Lukens E. Acute & chronic naltrexone decreases the hyperactivity of autism. Soc. Neurosci. Abstr. 1993;19:1785. [Google Scholar]
  • 220.Hernandez L.L., Watson K.L., Fowler B.M., Bair K. Selective opioid antagonists facilitate Pavlovian cardiac conditioning. Soc. Neurosci. Abstr. 1993;19:370. [Google Scholar]
  • 221.Highfield D.A., Grant S.J., Revay R.S. Nitric oxide modulates opioid tolerance in LC neuronal activity in vitro. Soc. Neurosci. Abstr. 1993;19:1460. [Google Scholar]
  • 222.Hikita H., Kurita A., Takase B. Usefulness of plasma beta-endorphin level, pain threshold and autonomic function in assessing silent myocardial ischemia in patients with and without diabetes mellitus. Am. J. Cardiol. 1993;72:140–143. doi: 10.1016/0002-9149(93)90149-7. [DOI] [PubMed] [Google Scholar]
  • 223.Hiller J.M., Fan L.Q., Simon E.J. Alternations in δ opioid receptor levels in discrete areas of the neocortex and in the globus pallidus of the aging guinea pig: A quantitative autoradiographic study. Brain Res. 1993;614:86–98. doi: 10.1016/0006-8993(93)91021-j. [DOI] [PubMed] [Google Scholar]
  • 224.Hockings G.I., Grice J.E., Ward W.K., Walters M.M., Jensen G.R., Jackson R.V. Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in posttraumatic stress disorder. Biol. Psychiatry. 1993;33:585–593. doi: 10.1016/0006-3223(93)90096-v. [DOI] [PubMed] [Google Scholar]
  • 225.Hoehner P.J., Whitson J.T., Kirsch J.R., Traystman R.J. Effect of intracarotid and intraventricular morphine on regional cerebral blood flow and metabolism in pentobarbital-anesthetized dogs. Anesth. Analg. 1993;76:266–273. doi: 10.1213/00000539-199302000-00011. [DOI] [PubMed] [Google Scholar]
  • 226.Hoffman W.E., Cunningham F., James M.K., Baughman V.L., Albrecht R.F. Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. Anesthesiology. 1993;79:107–113. doi: 10.1097/00000542-199307000-00016. [DOI] [PubMed] [Google Scholar]
  • 227.Holland L.N., Shuster L.C., Buccafusco J.J. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat. Neuropharmacology. 1993;32:1387–1395. doi: 10.1016/0028-3908(93)90035-2. [DOI] [PubMed] [Google Scholar]
  • 228.Holmes P.V., de Bartolomeis A., Koprovica V., Crawley I.N. In situ hybridization analysis of neuropeptide mRNA levels in locus coeruleus neurons following morphine withdrawal in rats. Soc. Neurosci. Abstr. 1993;19:1246. [Google Scholar]
  • 229.Hong J.S., McGinty J.F., Lee P.H.K., Xie C.W., Mitchell C.L. Relationship between hippocampal opioid peptides and seizures. Prog. Neurobiol. 1993;40:507–528. doi: 10.1016/0301-0082(93)90020-s. [DOI] [PubMed] [Google Scholar]
  • 230.Hong M., Milne B., Jhamandas K. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: An in vivo voltammetric study in the rat locus coeruleus. Brain Res. 1993;623:131–141. doi: 10.1016/0006-8993(93)90020-n. [DOI] [PubMed] [Google Scholar]
  • 231.Horan P.J., Porreca F. Lack of cross-tolerance between U69,593 and bremazocine suggests κ-opioid receptor multiplicity in mice. Eur. J. Pharmacol. 1993;239:93–98. doi: 10.1016/0014-2999(93)90980-v. [DOI] [PubMed] [Google Scholar]
  • 232.Hubbell C.L., Mankes R.F., Reid L.D. A small dose of morphine leads rats to drink more alcohol and achieve higher blood alcohol concentrations. Alcohol.: Clin. Exp. Res. 1993;17:1040–1043. doi: 10.1111/j.1530-0277.1993.tb05661.x. [DOI] [PubMed] [Google Scholar]
  • 233.Hubbell C.L., McCutcheon N.B. Opioidergic manipulations affect intake of 3% NaCl in sodium-deficient rats. Pharmacol. Biochem. Behav. 1993;46:473–476. doi: 10.1016/0091-3057(93)90382-4. [DOI] [PubMed] [Google Scholar]
  • 234.Huston-Lyons D., Sarkar M., Kornetsky C. Nicotine and brain-stimulation reward: Interactions with morphine, amphetamine and pimozide. Pharmacol. Biochem. Behav. 1993;46:453–457. doi: 10.1016/0091-3057(93)90378-7. [DOI] [PubMed] [Google Scholar]
  • 235.Hyytia P. Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol. Biochem. Behav. 1993;45:697–701. doi: 10.1016/0091-3057(93)90527-z. [DOI] [PubMed] [Google Scholar]
  • 236.Hyytia P., Sinclair J.D. Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol.: Clin. Exp. Res. 1993;17:631–636. doi: 10.1111/j.1530-0277.1993.tb00810.x. [DOI] [PubMed] [Google Scholar]
  • 237.Ibanez-Rojo V., Palanca I., Iruela L.M., Oliveros S.C., Caballero L., Baca E. Case report 4: Naltrexone-induced opiate withdrawal-like syndrome in a nonaddict obese women. J. Drug Dev. 1993;6:75–76. [Google Scholar]
  • 238.Igawa Y., Westerling D., Mattiasson A., Andersson K.-E. Effects of morphine metabolites on micturition in normal, unanaesthetized rats. Br. J. Pharmacol. 1993;110:257–262. doi: 10.1111/j.1476-5381.1993.tb13802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 239.Intorre L., Mengozzi G., Vanni E., Grassi F., Soldani G. The role of peripheral opioid receptor subtypes in the modulation of gastric acid secretion and plasma gastrin in dogs. Eur. J. Pharmacol. 1993;243:265–272. doi: 10.1016/0014-2999(93)90184-j. [DOI] [PubMed] [Google Scholar]
  • 240.Islam A.K., Beczkowska I.W., Bodnar R.J. Interactions among aging, gender, and gonadectomy effects upon naloxone hypophagia in rats. Physiol. Behav. 1993;54:981–992. doi: 10.1016/0031-9384(93)90312-4. [DOI] [PubMed] [Google Scholar]
  • 241.Islam A.K., Doughtery T., Koch J.E., Bodnar R.J. Opioid and serotonergic interactions: Effects upon carbohydrate intake in rats. Soc. Neurosci. Abstr. 1993;19:1820. [Google Scholar]
  • 242.Ito H., Goto S., Sakamoto S., Hirano A. Striosomal arrangement of met-enkephalin and substance P expression in parkinsonism-dementia complex on Guam. Acta Neuropathol. (Berl.) 1993;85:390–393. doi: 10.1007/BF00334449. [DOI] [PubMed] [Google Scholar]
  • 243.Itoh J., Ukai M., Kameyama T. Dynorphin A-(1–13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur. J. Pharmacol. 1993;236:341–345. doi: 10.1016/0014-2999(93)90469-x. [DOI] [PubMed] [Google Scholar]
  • 244.Itoh J., Ukai M., Kameyama T. Dynorphin A-(1–13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. Eur. J. Pharmacol. 1993;234:9–15. doi: 10.1016/0014-2999(93)90699-i. [DOI] [PubMed] [Google Scholar]
  • 245.Itoh J., Ukai M., Kameyama T. U-50,488H, a κ-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Res. 1993;619:223–228. doi: 10.1016/0006-8993(93)91615-y. [DOI] [PubMed] [Google Scholar]
  • 246.Jaeger T.V., van der Kooy D. Morphine acts in the parabrachial nucleus, a pontine viscerosensory relay, to produce discriminative stimulus effects. Psychopharmacology (Berlin) 1993;110:76–84. doi: 10.1007/BF02246953. [DOI] [PubMed] [Google Scholar]
  • 247.Jang W., Schadt J.D., Gaddis R.R. Peripheral opioidergic mechanisms do not mediate naloxone's pressor effect in the conscious rabbit. Circ. Shock. 1993;39:121–127. [PubMed] [Google Scholar]
  • 248.Jansen K.L.R., Faull R.L.M., Storey P., Leslie R.A. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss. Brain Res. 1993;623:299–302. doi: 10.1016/0006-8993(93)91441-t. [DOI] [PubMed] [Google Scholar]
  • 249.Jaw S.P., Hoskins B., Ho I.K. Comparison of butorphanol withdrawal syndromes precipitated by opioid receptor antagonists: Norbinaltorphimine (nor-BNI), naltrindole (NTI) and naloxone (NLX) Soc. Neurosci. Abstr. 1993;19:1246. [Google Scholar]
  • 250.Jaw S.P., Hoskins B., Ho I.K. Involvement of δ-opioid receptors in physical dependence on butorphanol. Eur. J. Pharmacol. 1993;240:67–72. doi: 10.1016/0014-2999(93)90546-t. [DOI] [PubMed] [Google Scholar]
  • 251.Jaw S.P., Hoskins B., Ho I.K. Opioid antagonists and butorphanol dependence. Pharmacol. Biochem. Behav. 1993;44:497–500. doi: 10.1016/0091-3057(93)90158-p. [DOI] [PubMed] [Google Scholar]
  • 252.Jaw S.P., Makimura M., Hoskins B., Ho I.K. Effects of norbinaltorphimine on butorphanol dependence. Eur. J. Pharmacol. 1993;239:133–140. doi: 10.1016/0014-2999(93)90986-r. [DOI] [PubMed] [Google Scholar]
  • 253.Jewett D.C., Negus S.S., Woods J.H. CTAP, naltrexone and naltrindole reduce deprivation-induced feeding in pigeons. Soc. Neurosci. Abstr. 1993;19:1819. [Google Scholar]
  • 254.Jimenez I., Fuentes J.A. Subchronic treatment with morphine inhibits the hypertension induced by isolation stress in the rat. Neuropharmacology. 1993;32:223–227. doi: 10.1016/0028-3908(93)90104-b. [DOI] [PubMed] [Google Scholar]
  • 255.Jimenez M., Martinez V., Gonalons E., Vergara P. In vivo modulation of gastrointestinal motor activity by met-enkephalin, morphine and enkephalin analogs in chickens. Regul. Pept. 1993;44:71–83. doi: 10.1016/0167-0115(93)90131-q. [DOI] [PubMed] [Google Scholar]
  • 256.Johansen O., Tonnesen T., Jensen T., Burhol P.G., Jorde R., Reikeras O. Morphine and morphine/naloxone modification of glucose, glucagon and insulin levels in fasted and fed rats. Scand. J. Clin. Lab. Invest. 1993;53:805–809. doi: 10.3109/00365519309086492. [DOI] [PubMed] [Google Scholar]
  • 257.Joharchi N., Sellers E.M., Higgins G.A. Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats. Psychopharmacology (Berlin) 1993;112:111–115. doi: 10.1007/BF02247370. [DOI] [PubMed] [Google Scholar]
  • 258.Johnson D.W., Glick S.D. Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats. Pharmacol. Biochem. Behav. 1993;46:341–347. doi: 10.1016/0091-3057(93)90362-w. [DOI] [PubMed] [Google Scholar]
  • 259.Johnson P.I., Stellar J.R., Paul A.D. Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist. Neuropharmacology. 1993;32:135–1314. doi: 10.1016/0028-3908(93)90025-x. [DOI] [PubMed] [Google Scholar]
  • 260.Jones D.N.C., Bowen W.D., Portoghese P.S., Holtzman S.G. δ-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur. J. Pharmacol. 1993;249:167–177. doi: 10.1016/0014-2999(93)90429-l. [DOI] [PubMed] [Google Scholar]
  • 261.Jones K., Wang S., Barr G.A. Precipitated withdrawal from chronic morphine in the week-old rat pup. Soc. Neurosci. Abstr. 1993;19:1249. [Google Scholar]
  • 262.Kalso E.A., Sullivan A.F., McQuay H.J., Dickenson A.H., Roques B.P. Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat. J. Pharmacol. Exp. Ther. 1993;265:551–558. [PubMed] [Google Scholar]
  • 263.Kamei J., Iwamoto Y., Kawashima N. Possible involvement of μ2-mediated mechanisms in μ-mediated antitussive activity in the mouse. Neurosci. Lett. 1993;149:169–172. doi: 10.1016/0304-3940(93)90763-b. [DOI] [PubMed] [Google Scholar]
  • 264.Kamei J., Iwamoto Y., Misawa M., Nagase H., Kasuya Y. Antitussive effect of β-endorphin is mediated by μ-opioid receptors, but not by κ- or ϵ-opioid receptors. Eur. J. Pharmacol. 1993;233:251–254. doi: 10.1016/0014-2999(93)90057-o. [DOI] [PubMed] [Google Scholar]
  • 265.Kamei J., Iwamoto Y., Suzuki T., Misawa M., Nagase H., Kasuya Y. Antitussive effects of μ- and κ-agonists in diabetic rats. Neurosci. Lett. 1993;154:65–68. doi: 10.1016/0304-3940(93)90172-h. [DOI] [PubMed] [Google Scholar]
  • 266.Kamei J., Iwamoto Y., Suzuki T., Misawa M., Nagase H., Kasuya Y. The role of the μ2-opioid receptor in the antitussive effect of morphine in μ1-opioid receptor-deficient CXBK mice. Eur. J. Pharmacol. 1993;240:99–101. doi: 10.1016/0014-2999(93)90553-t. [DOI] [PubMed] [Google Scholar]
  • 267.Kamei J., Iwamoto Y., Suzuki T., Nagase H., Misawa M., Kasuya Y. Differential modulation of μ-opioid receptor-mediated antitussive activity by δ-opioid receptor agonists in mice. Eur. J. Pharmacol. 1993;234:117–120. doi: 10.1016/0014-2999(93)90714-s. [DOI] [PubMed] [Google Scholar]
  • 268.Kamien J.B., Bickel W.K., Hughes J.R., Higgins S.T., Smith B.J. Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology (Berlin) 1993;111:259–270. doi: 10.1007/BF02244940. [DOI] [PubMed] [Google Scholar]
  • 269.Kanarek R.B., Ryu M., Olivardia R., Chang E., Marks-Kaufman R. Frequency of exposure but not diet affects analgesia produced by intermittent cold water swims. Soc. Neurosci. Abstr. 1993;19:1619. [Google Scholar]
  • 270.Kanof P.D., Aronson M.J., Ness R. Organic mood syndrome associated with detoxification from methadone maintenance. Am. J. Psychiatry. 1993;150:423–428. doi: 10.1176/ajp.150.3.423. [DOI] [PubMed] [Google Scholar]
  • 271.Kapusta D.R., Obih J.C. Central kappa opioid receptor-evoked changed in renal function in conscious rats: Participation of renal nerves. J. Pharmacol. Exp. Ther. 1993;267:197–204. [PubMed] [Google Scholar]
  • 272.Kapusta D.R., Obih J.C., Dimona G.F. Central mu opioid receptor-mediated changes in renal function in conscious rats. J. Pharmacol. Exp. Ther. 1993;265:134–143. [PubMed] [Google Scholar]
  • 273.Kasai M., Tasker J.G., Wuarin J.-P., Dudek F.E. Membrane properties of identified guinea-pig paraventricular neurons and their response to an opioid μ-receptor agonist: Evidence for an increase in K+ conductance. J. Neuroendocrinol. 1993;5:233–240. doi: 10.1111/j.1365-2826.1993.tb00478.x. [DOI] [PubMed] [Google Scholar]
  • 274.Kavaliers M., Colwell D.D. Neuropeptide FF (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice. Neurosci. Lett. 1993;157:75–78. doi: 10.1016/0304-3940(93)90646-3. [DOI] [PubMed] [Google Scholar]
  • 275.Kavaliers M., Innes D.G.L. Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia. Peptides. 1993;14:1001–1004. doi: 10.1016/0196-9781(93)90077-t. [DOI] [PubMed] [Google Scholar]
  • 276.Kavaliers M., Ossenkopp K.-P. Repeated naloxone treatments and exposures to weak 60-Hz magnetic fields have “analgesic” effects in snails. Brain Res. 1993;620:159–162. doi: 10.1016/0006-8993(93)90285-u. [DOI] [PubMed] [Google Scholar]
  • 277.Kearse L.A., Jr., Koski G., Husain M.W., Philbin D.M., McPeck K. Epileptiform activity during opioid anesthesia. Electroencephalogr. Clin. Neurophysiol. 1993;87:374–379. doi: 10.1016/0013-4694(93)90150-t. [DOI] [PubMed] [Google Scholar]
  • 278.Kemenes G., S.-Rozsa K., Carpenter D.O. Cyclic-AMP-mediated excitatory responses to leucine enkephalin in Aplysia neurones. J. Exp. Biol. 1993;181:321–328. [Google Scholar]
  • 279.Kenney M.J., Seals D.R. Postexercise hypotension: Key features, mechanisms, and clinical significance. Hypertension. 1993;22:653–664. doi: 10.1161/01.hyp.22.5.653. [DOI] [PubMed] [Google Scholar]
  • 280.Khan R.M., Soliman M.R.I. Effects of benzodiazepine agonist, antagonist and inverse agonist on ethanol-induced changes in beta-endorphin levels in specific rat brain regions. Pharmacology. 1993;47:337–343. doi: 10.1159/000139116. [DOI] [PubMed] [Google Scholar]
  • 281.Kikuchi Y., Kita T., Tode T., Hirata J., Nagata I. Plasma β-endorphin levels in patients with gynaecological malignancies. Eur. J. Cancer. 1993;29A:776. doi: 10.1016/s0959-8049(05)80367-3. [DOI] [PubMed] [Google Scholar]
  • 282.Kilduff T.S., Krilowicz B., Milsom W.K., Trachsel L., Wang L.C.H. Sleep and mammalian hibernation: Homologous adaptations and homologous processes? Sleep. 1993;16:372–386. doi: 10.1093/sleep/16.4.372. [DOI] [PubMed] [Google Scholar]
  • 283.Kiliaan A.J., Holmgren S., Jonsson A.-C., Dekker K., Groot J.A. Neuropeptides in the intestine of two teleost species (Oreochromis mossambicus, Carassius auratus): Localization and electrophysiological effects on the epithelium. Cell Tissue Res. 1993;271:123–134. [Google Scholar]
  • 284.Kimes A.S., Maldonado R., Koob G.F., Ambrosio E., London E.D. Injections of methylnaloxonium into the locus coeruleus produce cerebral hypermetabolism in morphine-dependent rats. Soc. Neurosci. Abstr. 1993;19:1022. [Google Scholar]
  • 285.Kimes A.S., Vaupel D.B., London E.D. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology (Berlin) 1993;112:521–524. doi: 10.1007/BF02244904. [DOI] [PubMed] [Google Scholar]
  • 286.Kinsley C.H., Wellman J.C., Carr D.B., Graham A. Opioid regulation of parental behavior in juvenile rats. Pharmacol. Biochem. Behav. 1993;44:763–768. doi: 10.1016/0091-3057(93)90003-c. [DOI] [PubMed] [Google Scholar]
  • 287.Kirby K.C., Stitzer M.L. Opioid physical dependence development in humans: Effect of time between agonist pretreatments. Psychopharmacology (Berlin) 1993;112:511–517. doi: 10.1007/BF02244902. [DOI] [PubMed] [Google Scholar]
  • 288.Kitchen I. Lead toxicity and alternations in opioid systems. Neurotoxicology. 1993;14:115–124. [PubMed] [Google Scholar]
  • 289.Kitchen I., Kelly M. Effect of perinatal lead treatment on morphine dependence in the adult rat. Neurotoxicology. 1993;14:125–130. [PubMed] [Google Scholar]
  • 290.Kitchen I., Kelly M., Hunter J.C. Ontogenetic studies with [3H]-CI-977 reveal early development of κ-opioid sites in rat brain. Mol. Neuropharmacol. 1993;2:269–272. [Google Scholar]
  • 291.Kiyatkin E.A., Wise R.A., Gratton A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats. Synapse. 1993;14:60–72. doi: 10.1002/syn.890140109. [DOI] [PubMed] [Google Scholar]
  • 292.Koch J.E., Bodnar R.J. Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol. Behav. 1993;53:603–605. doi: 10.1016/0031-9384(93)90160-h. [DOI] [PubMed] [Google Scholar]
  • 293.Koch J.E., Bodnar R.J. Opioid receptor subtype antagonist effects on deprivation and glucoprivic macronutrient intake in rat. Soc. Neurosci. Abstr. 1993;19:1820. [Google Scholar]
  • 294.Koide S., Onishi H., Kataymam M., Yamagami S. Endogenous methionine enkephalin may play an anticonvulsant role in the seizure-susceptible El mouse. Neurochem. Res. 1993;18:1259–1262. doi: 10.1007/BF00975045. [DOI] [PubMed] [Google Scholar]
  • 295.Kosten T.R., Schottenfeld R., Ziedonis D., Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J. Nerv. Mental Dis. 1993;181:358–364. doi: 10.1097/00005053-199306000-00004. [DOI] [PubMed] [Google Scholar]
  • 296.Kotz C.M., Grace M.K., Billington C.J., Levine A.S. The effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res. 1993;631:325–328. doi: 10.1016/0006-8993(93)91552-4. [DOI] [PubMed] [Google Scholar]
  • 297.Kunihara M., Ohyama M., Nakano M. Effects of spiradoline mesylate, a selective μ-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia. Jpn. J. Pharmacol. 1993;62:223–230. doi: 10.1254/jjp.62.223. [DOI] [PubMed] [Google Scholar]
  • 298.Lake J.R., Pal B., Burgess K. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Soc. Neurosci. Abstr. 1993;19:1248. doi: 10.1016/0024-3205(93)90601-x. [DOI] [PubMed] [Google Scholar]
  • 299.Lau S.M., Tang F. The effect of haloperidol on Met-enkephalin, β-endorphin, substance P and cholecystokinin contents in the striatum and the pituitary of rats during aging. Soc. Neurosci. Abstr. 1993;19:897. doi: 10.1016/0278-5846(95)00234-0. [DOI] [PubMed] [Google Scholar]
  • 300.Le A.D., Poulos C.X., Quan B., Chow S. The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res. 1993;630:330–332. doi: 10.1016/0006-8993(93)90672-a. [DOI] [PubMed] [Google Scholar]
  • 301.Leissring M.A., Rosenzweig M.R., Bennett E.L., Rothman B.S. Effect of the mu agonist DAGO on memory formation in the 2-day-old chick. Soc. Neurosci. Abstr. 1993;19:370. [Google Scholar]
  • 302.Leone M., Sacerdote P., D'Amico D., Panerai A.E., Bussone G. Beta-endorphin levels are reduced in peripheral blood mononuclear cells of cluster headache patients. Cephalalgia. 1993;13:413–416. doi: 10.1046/j.1468-2982.1993.1306413.x. [DOI] [PubMed] [Google Scholar]
  • 303.Leoni L.M., Losa G.A. Effect of cocaine and morphine on neutral endopeptidase activity of human peripheral blood mononuclear cells cultured with lectins. Cell Biochem. Funct. 1993;11:211–219. doi: 10.1002/cbf.290110309. [DOI] [PubMed] [Google Scholar]
  • 304.Lerner A.G., Sigal M., Gelkopf M. Naltrexone abuse and risk of suicide. J. Nerv. Ment. Dis. 1993;181:706–707. doi: 10.1097/00005053-199311000-00012. [DOI] [PubMed] [Google Scholar]
  • 305.Leu S.-J.C., Singh V.K. Suppression of in vitro antibody production by corticotropin-releasing factor neurohormone. J. Neuroimmunol. 1993;45:23–30. doi: 10.1016/0165-5728(93)90159-v. [DOI] [PubMed] [Google Scholar]
  • 306.Levesque D., Holtzman S.G. The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency of morphine are additive. Brain Res. 1993;617:176–180. doi: 10.1016/0006-8993(93)90633-x. [DOI] [PubMed] [Google Scholar]
  • 307.Levine A.S., Weldon D.T., Grace M., Cleary J.P., Billington C.J. Naloxone's anorectic effect is dependent upon length of deprivation and palatability of food. Soc. Neurosci. Abstr. 1993;19:1694. [Google Scholar]
  • 308.Levine F.M., Krass S.M., Padawer W.J. Failure hurts: The effects of stress due to difficult tasks and failure feedback on pain report. Pain. 1993;54:335–340. doi: 10.1016/0304-3959(93)90034-M. [DOI] [PubMed] [Google Scholar]
  • 309.Li W.I., Jiao S., Chen C.L., Bazer F.W. Secretion of immunoreactive β-endorphin and GnRH by the pig uterus: Effects of reproductive status and breed. J. Reprod. Fertil. 1993;99:253–258. doi: 10.1530/jrf.0.0990253. [DOI] [PubMed] [Google Scholar]
  • 310.Liminga U., Gunne L.M. Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats. Behav. Brain Res. 1993;57:93–99. doi: 10.1016/0166-4328(93)90064-w. [DOI] [PubMed] [Google Scholar]
  • 311.Lissoni P., Meregalli S., Fossati V. Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapy. Tumori. 1993;79:198–201. doi: 10.1177/030089169307900308. [DOI] [PubMed] [Google Scholar]
  • 312.Lloyd J.M., Weiland N.G., Wise P.M. Age-related changes in opiate receptor densities in discrete hypothalamic nuclei of ovari-ectomized (OVX) and estradiol (E2)-treated rats. Mol. Cell. Neurosci. 1993;4:173–180. doi: 10.1006/mcne.1993.1021. [DOI] [PubMed] [Google Scholar]
  • 313.Lukens E., Herman B.H., Asleson G. Evaluation of acute versus chronic naltrexone on pain sensitivity in autistic children. Soc. Neurosci. Abstr. 1993;19:1785. [Google Scholar]
  • 314.Lyeth B.G., Liu S., Hamm R.J. Combined scopolamine and morphine treatment of traumatic brain injury in the rat. Brain Res. 1993;617:69–75. doi: 10.1016/0006-8993(93)90614-s. [DOI] [PubMed] [Google Scholar]
  • 315.Lysle D.T., Coussons M.E., Watts V.J., Bennett E.H., Dykstra L.A. Morphine-induced alternations of immune status: Dose dependence, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 1993;265:1071–1078. [PubMed] [Google Scholar]
  • 316.Maes M., Meltzer H., Cosyns P. Pituitary and adrenal hormone responsiveness to synacthen in melancholic subjects versus subjects with minor depression. Biol. Psychiatry. 1993;33:624–629. doi: 10.1016/0006-3223(93)90101-i. [DOI] [PubMed] [Google Scholar]
  • 317.Magnus-Ellenbroek B., Havemann-Reinecke U. Morphine-induced hyperactivity in rats: A rebound effect? Arch. Pharmacol. 1993;347:635–642. doi: 10.1007/BF00166947. [DOI] [PubMed] [Google Scholar]
  • 318.Magoul R., Dubourg P., Benjelloun W., Tramu G. Direct and indirect enkephalinergic synaptic inputs to the rat arcuate nucleus studied by combination of retrograde tracing and immunocytochemistry. Neuroscience. 1993;55:1055–1066. doi: 10.1016/0306-4522(93)90319-b. [DOI] [PubMed] [Google Scholar]
  • 319.Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 1993;605:128–138. doi: 10.1016/0006-8993(93)91364-x. [DOI] [PubMed] [Google Scholar]
  • 320.Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., Wilson O.B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berlin) 1993;112:339–342. doi: 10.1007/BF02244930. [DOI] [PubMed] [Google Scholar]
  • 321.Malin D.H., Payza K., Lake J.R. Enhanced antiopiate activity in peptidomimetics of FMRFamide containing Z-2,3-methanomethionine. Peptides. 1993;14:47–51. doi: 10.1016/0196-9781(93)90009-6. [DOI] [PubMed] [Google Scholar]
  • 322.Malin D.R., Zadina J.E., Lake J.R. Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats. Brain Res. 1993;610:169–171. doi: 10.1016/0006-8993(93)91233-i. [DOI] [PubMed] [Google Scholar]
  • 323.Manzanares J., Curham R.A., Lookingland K.J., Moore K.E. δ-opioid receptor-mediated regulation of central dopaminergic neurons in the rat. Eur. J. Pharmacol. 1993;249:107–112. doi: 10.1016/0014-2999(93)90668-8. [DOI] [PubMed] [Google Scholar]
  • 324.Marchant E., Mistlberger R.E. Circadian phase-response curves to morphine and activity in the mouse. Soc. Neurosci. Abstr. 1993;19:1814. [Google Scholar]
  • 325.Martel F.L., Nevison C.M., Rayment F.D., Simpson M.J.A., Keverne E.B. Opioid receptor blockade reduces maternal affect and social grooming in rhesus monkeys. Psychoneuroendocrinology. 1993;18:307–321. doi: 10.1016/0306-4530(93)90027-i. [DOI] [PubMed] [Google Scholar]
  • 326.Martin-Kleiner I., Gabrilovac J. Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonist. Immunopharmacol. Immunotoxicol. 1993;15:179–197. doi: 10.3109/08923979309025993. [DOI] [PubMed] [Google Scholar]
  • 327.Martinez M., Hernanz A., Gomez-Cerezo J., Pena J.M., Vazquez J.J., Arnalich F. Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia. Regul. Pept. 1993;49:109–117. doi: 10.1016/0167-0115(93)90432-8. [DOI] [PubMed] [Google Scholar]
  • 328.Matsuoka I., Maldonado R., Hanoune J., Roques B.P. Region specific increase in brain adenylyl cyclase mRNA is involved in morphine dependence. Soc. Neurosci. Abstr. 1993;19:1022. [Google Scholar]
  • 329.Matwyshyn G.A., Thorat S.N., Barjavel M., Gudehithlu K.P., Bhargava H.N. Comparative effects of MK-801 and NG-monomethyl-L-arginine (NMMA) on morphine abstinence syndrome. Soc. Neurosci. Abstr. 1993;19:1461. [Google Scholar]
  • 330.Mayo-Michelson L., Young G.A. Genetic profiles of morphine-induced EEG, EEG power spectra, and behavior in two inbred rat strains. Brain Res. Bull. 1993;30:79–84. doi: 10.1016/0361-9230(93)90041-9. [DOI] [PubMed] [Google Scholar]
  • 331.Mazumder S., Nath I., Dhar M.M. Immunomodulation of human T cell responses with receptor selective enkephalins. Immunol. Lett. 1993;35:33–38. doi: 10.1016/0165-2478(93)90144-q. [DOI] [PubMed] [Google Scholar]
  • 332.McCubbin J.A., Kaplan J.R., Manuck S.T., Adams M.R. Opioidergic inhibition of circulatory and endocrine stress responses in cynomolgus monkeys: A preliminary study. Psychosom. Med. 1993;55:23–28. doi: 10.1097/00006842-199301000-00005. [DOI] [PubMed] [Google Scholar]
  • 333.McIntosh T.K., Fernyak S., Hayes R.L., Faden A.I. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat. J. Neurotrauma. 1993;10:373–384. doi: 10.1089/neu.1993.10.373. [DOI] [PubMed] [Google Scholar]
  • 334.McNamara R.K., Skelton R.W. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res. Rev. 1993;18:33–49. doi: 10.1016/0165-0173(93)90006-l. [DOI] [PubMed] [Google Scholar]
  • 335.Medina V.M., Wang L., Gintzler A.R. Spinal cord dynorphin: Positive region-specific modulation during pregnancy and parturition. Brain Res. 1993;623:41–46. doi: 10.1016/0006-8993(93)90007-a. [DOI] [PubMed] [Google Scholar]
  • 336.Mei L., Han J.-S. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in the cardiovascular activities was mediated by CCK-B receptor. Sci. China. 1993;36:817–824. [PubMed] [Google Scholar]
  • 337.Mello N.D., Kamien J.B., Lukas S.E., Drieze J., Mendelson J.H. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys. Neuropsychopharmacology. 1993;8:45–55. doi: 10.1038/npp.1993.6. [DOI] [PubMed] [Google Scholar]
  • 338.Melton P.M., Riley A.L. An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure. Pharmacol. Biochem. Behav. 1993;46:237–242. doi: 10.1016/0091-3057(93)90347-v. [DOI] [PubMed] [Google Scholar]
  • 339.Menendez L., Andres-Trelles F., Hidalgo A., Baamonde A. Involvement of spinal κ opioid receptors in a type of foot shock induced analgesia in mice. Brain Res. 1993;611:264–271. doi: 10.1016/0006-8993(93)90512-l. [DOI] [PubMed] [Google Scholar]
  • 340.Menendez L., Andres-Trelles F., Hidalgo A., Baamonde A. Opioid foot shock-induced analgesia in mice acutely falls by stress prolongation. Physiol. Behav. 1993;53:1115–1119. doi: 10.1016/0031-9384(93)90367-o. [DOI] [PubMed] [Google Scholar]
  • 341.Meyer M.E. Intrastriatal injections of dynorphin A fragments potentiate the dorsal immobility response in rats. Pharmacol. Biochem. Behav. 1993;44:329–332. doi: 10.1016/0091-3057(93)90469-a. [DOI] [PubMed] [Google Scholar]
  • 342.Meyer M.E. The effects of methionine-enkephalin and its related metabolites upon the duration of the dorsal immobility response in rats. Pharmacol. Biochem. Behav. 1993;46:841–845. doi: 10.1016/0091-3057(93)90210-k. [DOI] [PubMed] [Google Scholar]
  • 343.Meyer M.E., Meyer M.E. Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities. Pharmacol. Biochem. Behav. 1993;45:315–320. doi: 10.1016/0091-3057(93)90245-o. [DOI] [PubMed] [Google Scholar]
  • 344.Meyer M.E., Meyer M.E. Behavioral effects of the μ-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities. Pharmacol. Biochem. Behav. 1993;46:391–395. doi: 10.1016/0091-3057(93)90369-5. [DOI] [PubMed] [Google Scholar]
  • 345.Milanes M.V., Puig M.M., Vargas M.L. Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance. Neuropeptides. 1993;24:279–284. doi: 10.1016/0143-4179(93)90016-4. [DOI] [PubMed] [Google Scholar]
  • 346.Mitch C.H., Leander J.D., Mendelsohn L.G. 3,4-dimethyl-4-(3-hydroxphenyl)piperidines: Opioid antagonists with potent anorectant activity. J. Med. Chem. 1993;36:2842–2850. doi: 10.1021/jm00072a002. [DOI] [PubMed] [Google Scholar]
  • 347.Mitev Y., Almeida O.F.X., Patchev V. Pituitary-adrenal function and hypothalamic beta-endorphin release in vitro following food deprivation. Brain Res. Bull. 1993;30:7–10. doi: 10.1016/0361-9230(93)90033-8. [DOI] [PubMed] [Google Scholar]
  • 348.Miyamoto Y., Portoghese P.S., Takemori A.E. Involvement of δ2 opioid receptors in acute dependence on morphine in mice. J. Pharmacol. Exp. Ther. 1993;265:1325–1327. [PubMed] [Google Scholar]
  • 349.Miyamoto Y., Portoghese P.S., Takemori A.E. Involvement of delta2 opioid receptors in the development of morphine dependence in mice. J. Pharmacol. Exp. Ther. 1993;264:1141–1145. [PubMed] [Google Scholar]
  • 350.Miyamoto Y., Takemori A.E. Inhibition of naloxone-precipitated withdrawal jumping by ICV and i.t. administration of saline in morphine-dependent mice. Life Sci. 1993;52:1129–1134. doi: 10.1016/0024-3205(93)90434-5. [DOI] [PubMed] [Google Scholar]
  • 351.Miyamoto Y., Takemori A.E. Relative involvement of supraspinal and spinal μ opioid receptors in morphine dependence in mice. Life Sci. 1993;52:1039–1044. doi: 10.1016/0024-3205(93)90196-a. [DOI] [PubMed] [Google Scholar]
  • 352.Miyamoto Y., Takemori A.E. Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: Investigations by the ED5 value and CNS content of naloxone. Drug Alcohol Depend. 1993;32:163–167. doi: 10.1016/0376-8716(93)80009-4. [DOI] [PubMed] [Google Scholar]
  • 353.Mogil J.S., Shomer M., Chang W.-C., Kao B., Liebeskind J.C. Inverse genetic correlation between morphine analgesia and hyperlocomotion in mice selectively bred for stress-induced analgesia. Soc. Neurosci. Abstr. 1993;19:1786. [Google Scholar]
  • 354.Mogil J.S., Sternberg W.F., Kest B., Marek P., Liebeskind J.C. Sex differences in the antagonism of swim stress-induced analgesia: Effects of gonadectomy and estrogen replacement. Pain. 1993;53:17–25. doi: 10.1016/0304-3959(93)90050-Y. [DOI] [PubMed] [Google Scholar]
  • 355.Moroz L.L., Winlow W. Met-enkephalin modulated rhythmic activity in central neurons of Lymnaea stagnalis. Comp. Biochem. Physiol. [C] 1993;106:179–187. [Google Scholar]
  • 356.Morphy M.A., Fava G.A., Sonino N. β-endorphin responsiveness in depression. Arch. Gen. Psychiatry. 1993;50:406–407. doi: 10.1001/archpsyc.1993.01820170092011. [DOI] [PubMed] [Google Scholar]
  • 357.Morrone L.A., Romanelli L., Amico M.C., Valeri P. Withdrawal contractures of guinea-pig isolated ileum after acute activation of κ-opioid receptors. Br. J. Pharmacol. 1993;109:48–52. doi: 10.1111/j.1476-5381.1993.tb13529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 358.Mosnaim A.D., Wolf M.E., Maturana P. In vitro studies of natural killer cell activity in post traumatic stress disorder patients: Response to methionine-enkephalin challenge. Immunopharmacology. 1993;25:107–116. doi: 10.1016/0162-3109(93)90014-h. [DOI] [PubMed] [Google Scholar]
  • 359.Mosnaim A.D., Wolf M.E., Maturana P., Puente J., Freitag F.G., Diamond S. In vitro studies of natural killer cell activity in migraineurs: Changes in response to methionine-enkephalin challenge during an acute migraine episode. Head. Q. 1993;4:36–41. [Google Scholar]
  • 360.Moss I.R., Faltus R.E., Inman J.G., Laferriere A. Kappa opioid influence on cardiorespiratory and state control during postnatal development. Soc. Neurosci. Abstr. 1993;19:1490. [Google Scholar]
  • 361.Moss I.R., Scott S.C., Inman J.D.G. μ- vs. δ-opioid influence on respiratory and sleep behavior during development. Am. J. Physiol. 1993;264:R754–R760. doi: 10.1152/ajpregu.1993.264.4.R754. [DOI] [PubMed] [Google Scholar]
  • 362.Motta V., Brandao M.L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol. Biochem. Behav. 1993;44:119–125. doi: 10.1016/0091-3057(93)90288-5. [DOI] [PubMed] [Google Scholar]
  • 363.Moufid-Bellancourt S., Razafimanalina R., Velley L. Opiate modulation of palatability by the second gustatory relay: Implication of lateral hypothalamic neurones. Soc. Neurosci. Abstr. 1993;19:1787. [Google Scholar]
  • 364.Moy N.A., Aguirre Z.J., Flores A.M., Pacheco M.F. Antiepileptic actions of dynorphin and naloxone on CA3 pyramidal cells of guinea pig hippocampus. Soc. Neurosci. Abstr. 1993;19:1870. [Google Scholar]
  • 365.Muhammad B.Y., Kitchen I. A method for the study of swimming stress and stress-induced antinociception in preweanling rats. J. Pharmacol. Toxicol. Methods. 1993;29:139–141. doi: 10.1016/1056-8719(93)90064-l. [DOI] [PubMed] [Google Scholar]
  • 366.Muhammad B.Y., Kitchen I. Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat. Br. J. Pharmacol. 1993;109:651–654. doi: 10.1111/j.1476-5381.1993.tb13622.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 367.Murakami F., Araki T., Kanai Y., Kato H., Kogure K. Effect of vinconate against alteration in [3H]naloxone, [3H]MK-801 and [3H]muscimol bindings after transient cerebral ischemia in gerbils. Arch. Int. Pharmacodyn. Ther. 1993;325:21–34. [PubMed] [Google Scholar]
  • 368.Nah S.-Y., Saya D., Vogel Z. Long-term opiate exposure leads to increase in synapsin I in rat spinal cord-dorsal root ganglion cocultures. J. Neurochem. 1993;60:1147–1150. doi: 10.1111/j.1471-4159.1993.tb03266.x. [DOI] [PubMed] [Google Scholar]
  • 369.Narita M., Suzuki T., Funada M., Misawa M., Nagase H. Involvement of δ-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology (Berlin) 1993;111:423–426. doi: 10.1007/BF02253531. [DOI] [PubMed] [Google Scholar]
  • 370.Narita M., Takahashi Y., Takamori K. Effects of κ-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn. J. Pharmacol. 1993;62:15–24. doi: 10.1254/jjp.62.15. [DOI] [PubMed] [Google Scholar]
  • 371.Negus S.S., Burke T.F., Medzihradsky F., Woods J.H. Effects of opioid agonists selective to mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine. J. Pharmacol. Exp. Ther. 1993;267:896–903. [PubMed] [Google Scholar]
  • 372.Negus S.S., Henriksen S.J., Mattox A. Effect of antagonists selective for mu, kappa and delta opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 1993;265:1245–1252. [PubMed] [Google Scholar]
  • 373.Negus S.S., Pasternak G.W., Koob G.F., Weinger M.B. Antagonist effects of β-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat. J. Pharmacol. Exp. Ther. 1993;264:739–745. [PubMed] [Google Scholar]
  • 374.Nichols D.G., Waster M., Lynn A.M. Disposition and respiratory effects of intrathecal morphine in children. Anesthesiology. 1993;79:733–738. [PubMed] [Google Scholar]
  • 375.Nie Z., Yuan X., Madamba S.G., Siggins G.R. Ethanol decreases glutamatergic synaptic transmission in rat nucleus accumbens in vitro: Naloxone reversal. J. Pharmacol. Exp. Ther. 1993;266:1705–1712. [PubMed] [Google Scholar]
  • 376.Nightingale S.L. Levomethadyl approved for the treatment of opiate dependence. JAMA. 1993;270:1290. [Google Scholar]
  • 377.Nikolopoulou V., Lafi T., Gogos C., Athanassiadou A., Zoumbos N. Lymphocytes from patients with chronic duodenal ulcer disease show enhanced proliferative response to β-endorphin. Hepatogastroenterology. 1993;40:116–119. [PubMed] [Google Scholar]
  • 378.Noble F., Fournie-Zaluski M.-C., Roques B.P. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice. Eur. J. Pharmacol. 1993;230:139–149. doi: 10.1016/0014-2999(93)90796-k. [DOI] [PubMed] [Google Scholar]
  • 379.Noel M.B., Wise R.A. Ventral tegmental injections of morphine but not U-50,488H enhance feeding in food-deprived rats. Brain Res. 1993;632:68–73. doi: 10.1016/0006-8993(93)91139-j. [DOI] [PubMed] [Google Scholar]
  • 380.Nyberg K., Allebeck P., Eklund G., Jacobson B. Obstetric medication versus residential area as perinatal risk factors for subsequent adult drug addiction in offspring. Paediatr. Perinat. Epidemiol. 1993;7:23–32. doi: 10.1111/j.1365-3016.1993.tb00598.x. [DOI] [PubMed] [Google Scholar]
  • 381.Oberling P., Rocha B., Di Scala G., Sandner G. Evidence for state-dependent retrieval in conditioned place aversion. Behav. Neural Biol. 1993;60:27–32. doi: 10.1016/0163-1047(93)90677-a. [DOI] [PubMed] [Google Scholar]
  • 382.Olmstead M.C., Munn E.M., Wise R.A. Effects of pedunculopontine nucleus (PNN) lesions on the acquisition of IV heroin self-administration. Soc. Neurosci. Abstr. 1993;19:1023. [Google Scholar]
  • 383.Osadchiy O.E., Pokrovsky V.M., Cherednik I.L., Kurzanov A.N. Met-enkephalin action on the sinus arrhythmia during burst stimulation of the vagus nerve. Bull. Exp. Biol. Med. 1993;116:6. [PubMed] [Google Scholar]
  • 384.Paakkari P., Paakkari I., Landes P., Siren A.-L., Feuerstein G. Respiratory μ-opioid and benzodiazepine interactions in the unrestrained rat. Neuropharmacology. 1993;32:323–329. doi: 10.1016/0028-3908(93)90152-s. [DOI] [PubMed] [Google Scholar]
  • 385.Parsadaniantz S.M., Lenoir V., Terlain B., Kerdelhue B. Lack of effect of interleukins 1α and 1β, during in vitro perfusion, on anterior pituitary release of adrenocorticotropic hormone and β endorphin in the male rat. J. Neurosci. Res. 1993;34:315–323. doi: 10.1002/jnr.490340308. [DOI] [PubMed] [Google Scholar]
  • 386.Pasquali R., Casimirri F., Cantobelli S. β-endorphin response to exogenous corticotrophin-releasing hormone in obese women with different patterns of body fat distribution. Int. J. Obes. 1993;17:593–596. [PubMed] [Google Scholar]
  • 387.Pavlovic Z., Bodnar R.J. Antinociceptive and hypothermic crosstolerance between continuous and intermittent cold-water swims in rats. Physiol. Behav. 1993;54:1081–1084. doi: 10.1016/0031-9384(93)90328-d. [DOI] [PubMed] [Google Scholar]
  • 388.Perez-Navarro E., Alberch J., Marsal J. Postnatal development of functional dopamine, opioid and tachykinin receptors that regulate acetylcholine release from rat neostriatal slices: Effect of 6-hydroxydopamine lesion. Int. J. Dev. Neurosci. 1993;11:701–708. doi: 10.1016/0736-5748(93)90059-m. [DOI] [PubMed] [Google Scholar]
  • 389.Perry D.C., Getz R., Lee I.Y., Panchison D., Okuda Y., Miller L.P. Forebrain ischemia in the gerbil increases λ opiate binding in hippocampal mossy fibers. Brain Res. 1993;617:296–302. doi: 10.1016/0006-8993(93)91097-c. [DOI] [PubMed] [Google Scholar]
  • 390.Persson S., Jonsdottir I., Thoren P., Post C., Nyberg F., Hoffmann P. Cerebrospinal fluid dynorphin-converting enzyme activity is increased by voluntary exercise in the spontaneously hypertensive rat. Life Sci. 1993;53:643–652. doi: 10.1016/0024-3205(93)90274-7. [DOI] [PubMed] [Google Scholar]
  • 391.Peterson P.K., Molitor T.W., Chao C.C. Mechanisms of morphine-induced immunomodulation. Biochem. Pharmacol. 1993;46:343–348. doi: 10.1016/0006-2952(93)90508-t. [DOI] [PubMed] [Google Scholar]
  • 392.Petrie B.F. Naltrexone does not increase brain and body development in rats. Neurotox. Teratol. 1993;15:275–277. doi: 10.1016/0892-0362(93)90009-d. [DOI] [PubMed] [Google Scholar]
  • 393.Petrozzino J.J., Scardella A.T., Ecelman N.H., Santiago T.V. Respiratory muscle acidosis stimulates endogenous opioids during inspiratory loading. Am. Rev. Respir. Dis. 1993;147:67–615. doi: 10.1164/ajrccm/147.3.607. [DOI] [PubMed] [Google Scholar]
  • 394.Philopena J., Smith G.P. Ontogeny of opioid mediation of sucrose intake in the rat. Soc. Neurosci. Abstr. 1993;19:1819. [Google Scholar]
  • 395.Picazo O., Fernandez-Guasti A. Changes in experimental anxiety during pregnancy and lactation. Physiol. Behav. 1993;54:295–299. doi: 10.1016/0031-9384(93)90114-u. [DOI] [PubMed] [Google Scholar]
  • 396.Picker M.J., Yarbrough J., Hughes C.E., Smith M.A., Morgan D., Dykstra L.A. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: Influence of training dose, intrinsic efficacy and interanimal differences. J. Pharmacol. Exp. Ther. 1993;266:756–767. [PubMed] [Google Scholar]
  • 397.Piguet P., North R.A. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro. J. Pharmacol. Exp. Ther. 1993;266:1139–1146. [PubMed] [Google Scholar]
  • 398.Piva F., Celotti F., Dondi D. Ageing of the neuroendocrine system in the brain of male rats: Receptor mechanisms and steroid metabolism. J. Reprod. Fertil. 1993;(Suppl. 46):47–59. [PubMed] [Google Scholar]
  • 399.Pokela M.-L. Effect of opioid-induced analgesia on β-endorphin, cortisol and glucose responses in neonates with cardiorespiratory problems. Biol. Neonate. 1993;64:360–367. doi: 10.1159/000244012. [DOI] [PubMed] [Google Scholar]
  • 400.Pournaghash S., Riley A.L. Buprenorphine as a stimulus in drug discrimination learning: An assessment of mu and kappa receptor activity. Pharmacol. Biochem. Behav. 1993;46:593–604. doi: 10.1016/0091-3057(93)90549-9. [DOI] [PubMed] [Google Scholar]
  • 401.Pournaghash S., Riley A.L. Buprenorphine drug discrimination in opiate-dependent animals: An assessment of the kappa antagonist properties of buprenorphine. Soc. Neurosci. Abstr. 1993;19:1026. [Google Scholar]
  • 402.Preston K.L., Bigelow G.E. Differential naltrexone antagonism of hydromorphone and pentazocine effects of human volunteers. J. Pharmacol. Exp. Ther. 1993;264:813–823. [PubMed] [Google Scholar]
  • 403.Privette T.H., Terrian D.M. Anxiolytic effects and a putative site of action for the kappa opioid agonist U50,488H. Soc. Neurosci. Abstr. 1993;19:1786. [Google Scholar]
  • 404.Pugsley M.K., Saint D.A., Penz M.P., Walker M.J.A. Electrophysiological and antiarrhythmic actions in the κ agonist PD 129290, and its R,R (+)-enantiomer, PD 129289. Br. J. Pharmacol. 1993;110:1579–1585. doi: 10.1111/j.1476-5381.1993.tb14004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 405.Pujol A., De Cabo C., Martin M.I., Viveros M.P. A developmental study on stress-induced antinociception measured by the tail electric stimulation test. Pharmacol. Biochem. Behav. 1993;46:373–376. doi: 10.1016/0091-3057(93)90366-2. [DOI] [PubMed] [Google Scholar]
  • 406.Pumford K.M., Leng G., Russell J.A. A pertussis toxin-sensitive G protein mediates inhibition by morphine of spontaneous electrical activity of oxytocin neurones in anaesthetized rats. Exp. Brain Res. 1993;94:247–251. doi: 10.1007/BF00230292. [DOI] [PubMed] [Google Scholar]
  • 407.Pumford K.M., Russell J.A., Leng G. Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats. Exp. Brain Res. 1993;94:237–246. doi: 10.1007/BF00230291. [DOI] [PubMed] [Google Scholar]
  • 408.Qu Z.-X., Isaac L. Dynorphin A (1–13) potentiates dynorphin a (1–17) on loss of the tail-flick reflex after intrathecal injection in the rat. Brain Res. 1993;610:340–343. doi: 10.1016/0006-8993(93)91420-w. [DOI] [PubMed] [Google Scholar]
  • 409.Qu Z.-X., Xu J., Hogan E.L., Hsu C.Y. Effect of U-50488h, a selective opioid κ receptor agonist, on vascular injury after spinal cord trauma. Brain Res. 1993;626:45–49. doi: 10.1016/0006-8993(93)90561-z. [DOI] [PubMed] [Google Scholar]
  • 410.Rabkin S.W. Morphine and morphiceptin increase the threshold for epinephrine-induced cardiac arrhythmias in the rat through brain mu opioid receptors. Clin. Exp. Pharmacol. Physiol. 1993;20:95–102. doi: 10.1111/j.1440-1681.1993.tb00581.x. [DOI] [PubMed] [Google Scholar]
  • 411.Rabkin S.W. The opioid agonist ethylketocyclazocine accentuates epinephrine-induced cardiac arrhythmias in the rat through action in the brain. Brain Res. Bull. 1993;31:427–432. doi: 10.1016/0361-9230(93)90236-5. [DOI] [PubMed] [Google Scholar]
  • 412.Ramzan I., Wong B.K., Corcoran G.B. Pain sensitivity in dietary-induced obese rats. Physiol. Behav. 1993;54:433–435. doi: 10.1016/0031-9384(93)90231-4. [DOI] [PubMed] [Google Scholar]
  • 413.Randall C.K., Kraemer P.J., Valone J.M., Bardo M.T. Odor conditioning with morphine: Conditioned preference, aversion, and analgesia. Psychobiology. 1993;21:215–220. [Google Scholar]
  • 414.Randich A., Robertson J.D., Willingham T. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine. Brain Res. 1993;603:186–200. doi: 10.1016/0006-8993(93)91237-m. [DOI] [PubMed] [Google Scholar]
  • 415.Rapaport M.H., Wolkowitz O., Kelsoe J.R., Pato C., Konicki P.E., Pickar D. Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients. Neuropsychopharmacology. 1993;9:111–115. doi: 10.1038/npp.1993.49. [DOI] [PubMed] [Google Scholar]
  • 416.Reid L.D., Hubbell C.L., Glaccum M.B., Bilsky E.J., Portoghese P.S., Porreca F. Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation. Life Sci. 1993;52:PL67–PL71. doi: 10.1016/0024-3205(93)90084-g. [DOI] [PubMed] [Google Scholar]
  • 417.Rekling J.C. Effects of met-enkephalin on GABAergic spontaneous miniature IPSPs in organotypic slice cultures of the rat hippocampus. J. Neurosci. 1993;13:1954–1964. doi: 10.1523/JNEUROSCI.13-05-01954.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 418.Rhim H., Glaum S.R., Miller R.J. Selective opioid agonists modulate afferent transmission in the rat nucleus tractus solitarius. J. Pharmacol. Exp. Ther. 1993;264:795–800. [PubMed] [Google Scholar]
  • 419.Richter A., Loscher W. The κ-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia. Eur. J. Pharmacol. 1993;236:289–294. doi: 10.1016/0014-2999(93)90600-m. [DOI] [PubMed] [Google Scholar]
  • 420.Rimanoczy A., Vathy I. Effects of prenatal morphine on brain opiate receptors of adult male rats. Soc. Neurosci. Abstr. 1993;19:1249. [Google Scholar]
  • 421.Rinne J.O., Lonnberg P., Marjamaki P. Human brain methionine- and leucine-enkephalins and their receptors during ageing. Brain Res. 1993;624:131–136. doi: 10.1016/0006-8993(93)90070-4. [DOI] [PubMed] [Google Scholar]
  • 422.Rinne J.O., Lonnberg P., Marjamaki P., Molsa P., Sako E., Paljarvi L. Brain methionine- and leucine-enkephalin receptors in patients with dementia. Neurosci. Lett. 1993;161:77–80. doi: 10.1016/0304-3940(93)90144-a. [DOI] [PubMed] [Google Scholar]
  • 423.Roane D.S., Boyd N.E. Reduction of food intake and morphine analgesia by central glybenclamide. Pharmacol. Biochem. Behav. 1993;46:205–207. doi: 10.1016/0091-3057(93)90341-p. [DOI] [PubMed] [Google Scholar]
  • 424.Roberts D.C.S., Bennett S.A.L. Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology (Berlin) 1993;111:215–218. doi: 10.1007/BF02245526. [DOI] [PubMed] [Google Scholar]
  • 425.Robertson J.A., Bodnar R.J. Site-specific modulation of morphine and swim-induced antinociception following thyrotropin-releasing hormone in the rat periaqueductal gray. Pain. 1993;55:71–84. doi: 10.1016/0304-3959(93)90186-S. [DOI] [PubMed] [Google Scholar]
  • 426.Robinson S.R., Arnold H.M., Spear N.E., Smotherman W.P. Experience with milk and an artificial nipple promotes conditioned opioid activity in the rat fetus. Dev. Psychobiol. 1993;26:375–387. doi: 10.1002/dev.420260702. [DOI] [PubMed] [Google Scholar]
  • 427.Robinson S.R., Hoeltzel T.C.M., Smotherman W.P. Behavioral responses to an artificial nipple in the developing rat fetus: Effects of μ and κ opioid activity. Soc. Neurosci. Abstr. 1993;19:1787. [Google Scholar]
  • 428.Robinson S.R., Moody C.A., Spear L.P., Smotherman W.P. Effects of dopamine and kappa opioid receptors on fetal responsiveness to perioral stimuli. Dev. Psychobiol. 1993;26:37–50. doi: 10.1002/dev.420260104. [DOI] [PubMed] [Google Scholar]
  • 429.Rocha L., Ackermann R.F., Nassir Y., Chugani H.T., Engel J., Jr. Characterization of mu opioid receptor binding during amygdala kindling in rats and effects of chronic naloxone pretreatment: An autoradiographic study. Epilepsy Res. 1993;14:195–208. doi: 10.1016/0920-1211(93)90044-8. [DOI] [PubMed] [Google Scholar]
  • 430.Rocha L., Tatsukawa K., Chugani H.T., Engel J., Jr. Benzodiazepine receptor binding following chronic treatment with naloxone, morphine and met-enkephalin in normal rats. Brain Res. 1993;612:247–252. doi: 10.1016/0006-8993(93)91668-i. [DOI] [PubMed] [Google Scholar]
  • 431.Rochford J., Dawes P. Effect of naloxone on the habituation of novelty-induced hypoalgesia: The collateral inhibition hypothesis revisited. Pharmacol. Biochem. Behav. 1993;46:117–123. doi: 10.1016/0091-3057(93)90326-o. [DOI] [PubMed] [Google Scholar]
  • 432.Rochford J., Dawes P., Stewart J. Naloxone potentiation of novelty-induced hypoalgesia: Characterization of the α-noradrenergic receptor subtype. Pharmacol. Biochem. Behav. 1993;44:381–386. doi: 10.1016/0091-3057(93)90478-c. [DOI] [PubMed] [Google Scholar]
  • 433.Roge J., Baumer P., Berard H., Schwartz J.-C., Lecomte J.-M. The enkephalinase inhibitor, acetorphan, in acute diarrhoea: A double-blind, controlled clinical trial versus loperamide. Scand. J. Gastroenterol. 1993;28:352–354. doi: 10.3109/00365529309090255. [DOI] [PubMed] [Google Scholar]
  • 434.Rojavin M., Szabo I., Bussiere J.L., Rogers T.J., Adler M.W., Eisenstein T.K. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 1993;53:997–1006. doi: 10.1016/0024-3205(93)90122-j. [DOI] [PubMed] [Google Scholar]
  • 435.Rothman R.B., Brady L.S., Xu H., Long J.B. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain. Peptides. 1993;14:127–1277. doi: 10.1016/0196-9781(93)90187-l. [DOI] [PubMed] [Google Scholar]
  • 436.Rowlett J.K., Gibson T.R., Valone J.M., Bardo M.T. Conditioned place preference with buprenorphine: Interactions with naltrexone, morphine, and amphetamine. Soc. Neurosci. Abstr. 1993;19:1026. [Google Scholar]
  • 437.Rudski J.M., Billington C.J., Cleary J.P., Levine A.S. Butor-phanol decreases rats' latency to begin lever pressing and increases amount of food consumed in operant chambers. Soc. Neurosci. Abstr. 1993;19:1694. [Google Scholar]
  • 438.Ruegg H., Hahn B., Koch J.E., Bodnar R.J. Opioid receptor subtype antagonist effects on fluid intake following angiotensin II and hypertonic saline in rats. Soc. Neurosci. Abstr. 1993;19:1820. [Google Scholar]
  • 439.Ruiz F., Dierssen M., Florez J., Hurle M.A. Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats. Arch. Pharmacol. 1993;348:633–637. doi: 10.1007/BF00167240. [DOI] [PubMed] [Google Scholar]
  • 440.Ruiz F., Dierssen M., Florez J., Hurle M.A. The Ca2+ channel agonist Bay K 8644 induces central respiratory depression in cats, an effect blocked by naloxone. Eur. J. Pharmacol. 1993;240:155–161. doi: 10.1016/0014-2999(93)90893-m. [DOI] [PubMed] [Google Scholar]
  • 441.Rushen J., Foxcroft G., de Passille A.M. Nursing-induced changes in pain sensitivity, prolactin, and somatotropin in the pig. Physiol. Behav. 1993;53:265–270. doi: 10.1016/0031-9384(93)90203-r. [DOI] [PubMed] [Google Scholar]
  • 442.Russell J.A., Coombes J.E., Leng G., Bicknell R.J. Morphine tolerance and inhibition of oxytocin secretion by -opioids acting on the rat neurohypophysis. J. Physiol. 1993;469:365–386. doi: 10.1113/jphysiol.1993.sp019818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 443.Sacerdote P., Manfredi B., Bianchi M., Panerai A.E. Intermittent and continuous foot shock stress differentially modulate immunocyte beta-endorphin concentrations and immunity. Soc. Neurosci. Abstr. 1993;19:169. [Google Scholar]
  • 444.Saksida L.M., Galea L.A.M., Kavaliers M. Predator-induced opioid and nonopioid mediated analgesia in young meadow voles: Sex differences and developmental changes. Brain Res. 1993;617:214–219. doi: 10.1016/0006-8993(93)91088-a. [DOI] [PubMed] [Google Scholar]
  • 445.Samuels S., McIntosh T.K. Activation of κ-opioid receptors in the nucleus ambiguus does not affect cardiovascular function or outcome following acute hemorrhage in the rat. Brain Res. 1993;613:54–60. doi: 10.1016/0006-8993(93)90453-t. [DOI] [PubMed] [Google Scholar]
  • 446.Sanchez M.D., Milanes M.V., Fuente T., Laorden M.L. The β-endorphin response to prenatal stress during postnatal development in the rat. Dev. Brain Res. 1993;74:142–145. doi: 10.1016/0165-3806(93)90095-r. [DOI] [PubMed] [Google Scholar]
  • 447.Sankaran K., Hindmarsh K.W., Tan L., Kalapurackal M. Plasma β-endorphin concentration and xanthine treatment in apnea of prematurity. Clin. Invest. Med. 1993;16:197–203. [PubMed] [Google Scholar]
  • 448.Saphier D., Welch J.E., Chuluyan H.E. α-interferon inhibits adrenocortical secretion via μ1-opioid receptors in the rat. Eur. J. Pharmacol. 1993;236:183–191. doi: 10.1016/0014-2999(93)90588-9. [DOI] [PubMed] [Google Scholar]
  • 449.Sato A., Sato Y., Suzuki A., Uchida S. Neural mechanisms of the reflex inhibition and excitation of gastric motility elicited by acupuncture-like stimulation in anesthetized rats. Neurosci. Res. 1993;18:53–62. doi: 10.1016/0168-0102(93)90105-y. [DOI] [PubMed] [Google Scholar]
  • 450.Savory C.J., Carlisle A., Maxwell M.H., Mitchell M.A., Robertson G.W. Stress, arousal and opioid peptide-like immunoreactivity in restricted- and ad lib.-fed broiler breeder fowls. Comp. Biochem. Physiol. [A] 1993;106:587–594. [Google Scholar]
  • 451.Schaefer L.A., Hobbs D.J., Koch J.E., Bodnar R.J. Interactive effects of opioid and dopamine2 receptors upon deprivation and glucoprivic intake in rats. Soc. Neurosci. Abstr. 1993;19:1820. [Google Scholar]
  • 452.Schiffmann S.N., Vanderhaeghen J.-J. Age-related loss of mRNA encoding adenosine A2 receptor in the rat striatum. Neurosci. Lett. 1993;158:121–124. doi: 10.1016/0304-3940(93)90244-f. [DOI] [PubMed] [Google Scholar]
  • 453.Schoenen J., Lenaerts M., Gerard P. Inhibition of temporal second exteroceptive suppression produced by single or long-lasting electrical stimuli and noxious thermal stimuli in peripheral limbs: Effects of naloxone. In: Olesen J., Schoenen J., editors. Tension-type headache: Classification, mechanisms, and treatment. Raven Press; New York: 1993. pp. 181–185. [Google Scholar]
  • 454.Schoffelmeer A.N.M., Mulder A.H., Tjon Tien Ril H.K.G. Lasting changes in stimulus-secretion coupling in central nerve terminals upon morphine withdrawal. Soc. Neurosci. Abstr. 1993;19:1248. [Google Scholar]
  • 455.Schottenfeld R.S., Pakes J., Ziedonis D., Kosten T.R. Buprenorphine: Dose-related effects on cocaine and opioid use in cocaineabusing opioid-dependent humans. Biol. Psychiatry. 1993;34:66–74. doi: 10.1016/0006-3223(93)90258-f. [DOI] [PubMed] [Google Scholar]
  • 456.Schroeder J.E., McCleskey E.W. Inhibition of Ca2+ currents by a μ-opioid in a defined subset of rat sensory neurons. J. Neurosci. 1993;13:867–873. doi: 10.1523/JNEUROSCI.13-02-00867.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 457.Schulteis G., Carrera R., Markou A., Gold L.H., Koob G.F. Motivational consequences of naloxone-precipitated opiate withdrawal: A dose-response analysis. Soc. Neurosci. Abstr. 1993;19:1247. [Google Scholar]
  • 458.Schultzberg M., Nobel S. Differential induction by LPS of interleukin-1β mRNA in the rat adrenal gland. Soc. Neurosci. Abstr. 1993;19:96. [Google Scholar]
  • 459.Scoto G.M., Parenti C. Prevention of stress-induced gastric ulcers by μ- and δ-opioid agonists in the rat. J. Physiol. 1993;87:385–388. [PubMed] [Google Scholar]
  • 460.Seatriz J.V., Hammer R.P., Jr. Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res. Bull. 1993;30:523–527. doi: 10.1016/0361-9230(93)90078-p. [DOI] [PubMed] [Google Scholar]
  • 461.Shaham Y. Immobilization stress-induced oral opioid self-administration and withdrawal in rats: Role of conditioning factors and the effect of stress on “relapse” to opioid drugs. Psychopharmacology (Berlin) 1993;111:477–485. doi: 10.1007/BF02253539. [DOI] [PubMed] [Google Scholar]
  • 462.Shaham Y., Kelsey J.E., Stewart J. Associative factors in stress-induced sensitization to the behavioral activating effects of morphine. Soc. Neurosci. Abstr. 1993;19:1026. [Google Scholar]
  • 463.Shaham Y., Klein L.C., Alvares K., Grunberg N.E. Effect of stress on oral fentanyl consumption in rats in an operant self-administration paradigm. Pharmacol. Biochem. Behav. 1993;46:315–322. doi: 10.1016/0091-3057(93)90359-2. [DOI] [PubMed] [Google Scholar]
  • 464.Shaw W.N. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants. Pharmacol. Biochem. Behav. 1993;46:653–659. doi: 10.1016/0091-3057(93)90557-a. [DOI] [PubMed] [Google Scholar]
  • 465.Shelton S.E., Kalin N.H. Opiate regulation of affiliation between primate mothers and infants. Soc. Neurosci. Abstr. 1993;19:1787. [Google Scholar]
  • 466.Shieh G.-J., Walters D.E. Perinatal exposure to the kappa agonist U-50,488 alters the sensitivity of D2 but not D1 receptors in the brain of rat offspring. Soc. Neurosci. Abstr. 1993;19:1249. [Google Scholar]
  • 467.Shiekhattar R., Aston-Jones G. Modulation of opiate responses in brain noradrenergic neurons by the cyclic AMP cascade: Changes with chronic morphine. Neuroscience. 1993;57:879–885. doi: 10.1016/0306-4522(93)90032-b. [DOI] [PubMed] [Google Scholar]
  • 468.Shu J., Stevenson J.R., Zhou X. Modulation of cellular immune responses by cold water swim stress in the rat. Dev. Comp. Immunol. 1993;17:357–371. doi: 10.1016/0145-305x(93)90007-d. [DOI] [PubMed] [Google Scholar]
  • 469.Shukla V.K., Lemaire S., Ibrahim I.H., Cyr T.D., Chen Y., Michelot R. Design of potent and selective dynorphin A related peptides devoid of supraspinal motor effects in mice. Can. J. Physiol. Pharmacol. 1993;71:211–216. doi: 10.1139/y93-033. [DOI] [PubMed] [Google Scholar]
  • 470.Silva M., Nogueira J.C., Tomaz C. Effects of naloxone treatment on memory-enhancing properties of posttraining administration of substance P. Behav. Brain Res. 1993;56:101–106. doi: 10.1016/0166-4328(93)90026-m. [DOI] [PubMed] [Google Scholar]
  • 471.Simonetta G., Young I.R., Coulter C.L., Hey N.J., McMillen I.C. Fetal adrenalectomy does not affect circulating enkephalins in the sheep fetus during late gestation. Neuroendocrinology. 1993;57:408–415. doi: 10.1159/000126386. [DOI] [PubMed] [Google Scholar]
  • 472.Smith M.E., Hughes S. Pro-opiomelanocortin neuropeptide receptors on developing and dystrophic muscle fibers. Mol. Chem. Neuropathol. 1993;19:137–145. doi: 10.1007/BF03160174. [DOI] [PubMed] [Google Scholar]
  • 473.Smith F.L., Welch S.P., Dombrowski D.S., Dewey W.L. The role of endogenous opioids as mediators of the hypothermic effects of intrathecally administered calcium and calcitonin gene-related peptide in mice. J. Pharmacol. Exp. Ther. 1993;266:1407–1415. [PubMed] [Google Scholar]
  • 474.Smotherman W.P., Moody C.A., Spear L.P., Robinson S.R. Fetal behavior and the endogenous opioid system: D1 dopamine receptor interactions with the kappa opioid system. Physiol. Behav. 1993;53:191–197. doi: 10.1016/0031-9384(93)90030-j. [DOI] [PubMed] [Google Scholar]
  • 475.Smotherman W.P., Robinson S.R. Habituation to chemosensory stimuli in the rat fetus: Effects of endogenous kappa opioid activity. Behav. Neurosci. 1993;107:611–617. doi: 10.1037//0735-7044.107.4.611. [DOI] [PubMed] [Google Scholar]
  • 476.Smotherman W.P., Simonik D.K., Andersen S.L., Robinson S.R. Mu and kappa opioid systems modulate responses to cutaneous perioral stimulation in the fetal rat. Physiol. Behav. 1993;53:751–756. doi: 10.1016/0031-9384(93)90184-h. [DOI] [PubMed] [Google Scholar]
  • 477.Smurthwaite S.T., Riley A.L. Nalorphine as a stimulus in drug discrimination learning. Soc. Neurosci. Abstr. 1993;19:1180. [Google Scholar]
  • 478.Smythe J.W., McCormick C.M., Rochford J., Meaney M.J. Basal and morphine-induced nociceptive responses are altered by prenatal stress and neonatal handling in a gender-specific fashion. Soc. Neurosci. Abstr. 1993;19:170. [Google Scholar]
  • 479.Soghomonian J.-J. Effects of neonatal 6-hydroxydopamine injections on glutamate decarboxylase, preproenkephalin and dopamine D2 receptor mRNAs in the adult rat striatum. Brain Res. 1993;621:249–259. doi: 10.1016/0006-8993(93)90113-2. [DOI] [PubMed] [Google Scholar]
  • 480.Song D.D., Harlan R.E. Ontogeny of the proenkephalin system in the rat corpus striatum: Its relationship to dopaminergic innervation and transient compartmental expression. Neuroscience. 1993;52:883–909. doi: 10.1016/0306-4522(93)90536-o. [DOI] [PubMed] [Google Scholar]
  • 481.Spanagel R., Shippenberg T.S. Modulation of morphine-induced sensitization by endogenous κ opioid systems in the rat. Neurosci. Lett. 1993;153:232–236. doi: 10.1016/0304-3940(93)90329-j. [DOI] [PubMed] [Google Scholar]
  • 482.Sribanditmongkol P., Sheu M.-J., Tejwani G.A. Inhibition of morphine tolerance and dependence by diazepam. Soc. Neurosci. Abstr. 1993;19:1249. [Google Scholar]
  • 483.Stamidis H., Young G.A. Mu-delta opioid interactions III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole. Peptides. 1993;14:511–517. doi: 10.1016/0196-9781(93)90140-c. [DOI] [PubMed] [Google Scholar]
  • 484.Stefano G.B., Smith E.M., Cadet P., Hughes T.K., Jr. HIV gp120 alternation of DAMA and IL-1α induced chemotaxic responses in human and invertebrate immunocytes. J. Neuroimmunol. 1993;43:177–184. doi: 10.1016/0165-5728(93)90089-h. [DOI] [PubMed] [Google Scholar]
  • 485.Stevens C.W., Kirkendall K. Time course and magnitude of tolerance to the analgesic effects of systemic morphine in amphibians. Life Sci. 1993;52:PL11–PL116. doi: 10.1016/0024-3205(93)90097-m. [DOI] [PubMed] [Google Scholar]
  • 486.Stewart J., Badiani A. The kappa agonist, U50,488, increases the intake of sucrose solutions at high concentrations: Evidence for an effect on satiation. Soc. Neurosci. Abstr. 1993;19:1819. [Google Scholar]
  • 487.Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 1993;4:32–289. [PubMed] [Google Scholar]
  • 488.Stoessl A.J., Polanski E., Frydryszak H. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia. Mov. Disord. 1993;8:445–452. doi: 10.1002/mds.870080405. [DOI] [PubMed] [Google Scholar]
  • 489.Storm H., Rognum T.O., Saugstad O.D., Reichelt K.L. Elevated beta-endorphin immunoreactivity in the cerebrospinal fluid in victims of sudden infant death correlates with hypoxanthine in vitreous humour. Eur. J. Pediatr. 1993;152:935–938. doi: 10.1007/BF01957536. [DOI] [PubMed] [Google Scholar]
  • 490.Stornetta R.L., Norton F.E., Guyenet P.G. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 1993;624:19–28. doi: 10.1016/0006-8993(93)90055-r. [DOI] [PubMed] [Google Scholar]
  • 491.Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Dose-response effects of methadone in the treatment of opioid dependence. Ann. Intern. Med. 1993;119:23–27. doi: 10.7326/0003-4819-119-1-199307010-00004. [DOI] [PubMed] [Google Scholar]
  • 492.Stuart J.F., Dorow J., Feller D.J. μ-opiate receptor binding and function in HOT and COLD selected lines of mice. Pharmacol. Biochem. Behav. 1993;46:519–526. doi: 10.1016/0091-3057(93)90539-6. [DOI] [PubMed] [Google Scholar]
  • 493.Suzuki T., Funada M., Narita M., Misawa M., Nagase H. Morphine-induced place preference in the CXBK mouse: Characteristics of μ opioid receptor subtypes. Brain Res. 1993;602:45–52. doi: 10.1016/0006-8993(93)90239-j. [DOI] [PubMed] [Google Scholar]
  • 494.Suzuki T., Yoshiike M., Funada M., Mizoguchi H., Kamei J., Misawa M. Effect of cyclosporine A on the morphine-induced place preference. Neurosci. Lett. 1993;160:159–162. doi: 10.1016/0304-3940(93)90403-8. [DOI] [PubMed] [Google Scholar]
  • 495.Swain M.G., Vergalla J., Bergasa N.V., Jones E.A. Sympathetic nerves, but not the adrenal gland, contribute to elevated plasma levels of met-enkephalin in rats with acute cholestatic hepatitis. Regul. Pept. 1993;46:535–542. doi: 10.1016/0167-0115(93)90254-6. [DOI] [PubMed] [Google Scholar]
  • 496.Take S., Mori T., Katafuchi T., Hori T. Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am. J. Physiol. 1993;265:R453–R459. doi: 10.1152/ajpregu.1993.265.2.R453. [DOI] [PubMed] [Google Scholar]
  • 497.Takemori A.E., Loh H.H., Lee N.M. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J. Pharmacol. Exp. Ther. 1993;266:121–124. [PubMed] [Google Scholar]
  • 498.Tanaka T., Takeshita H., Kawahara R., Hazama H., Tanaka M. The role of wet-dog shakes during amygdaloid electrical and methionine-enkephalin kindling in rat. Brain Res. 1993;604:149–153. doi: 10.1016/0006-8993(93)90361-p. [DOI] [PubMed] [Google Scholar]
  • 499.Taylor B.K., Basbaum A.I. Increased dopamine metabolism in the rostral ventral medulla (RVM) during morphine analgesia, tolerance, and naloxone-precipitated withdrawal. Soc. Neurosci. Abstr. 1993;19:1248. [Google Scholar]
  • 500.Tejedor-Real P., Mico J.A., Maldonado R., Roques B.P., Gibert-Rahola J. Effect of mixed (RB 38A)) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. Biol. Psychiatry. 1993;34:07–10. doi: 10.1016/0006-3223(93)90262-c. [DOI] [PubMed] [Google Scholar]
  • 501.Tejwani G.A., Rattan A.K., Sribanditmongkol P., Sheu M.-J., Zuniga J., McDonald J.S. Inhibition of morphine-induced tolerance and dependence by a benzodiazepine receptor agonist midazolam in the rat. Anesth. Analg. 1993;76:1052–1060. doi: 10.1213/00000539-199305000-00025. [DOI] [PubMed] [Google Scholar]
  • 502.Theodore W.H., Leiderman D., Gaillard W., Khan I., Reeves P., Lloyd-Hontz K. The effect of naloxone on cerebral blood flow and glucose metabolism in patients with complex partial seizures. Epilepsy Res. 1993;16:51–54. doi: 10.1016/0920-1211(93)90039-a. [DOI] [PubMed] [Google Scholar]
  • 503.Thomas J., Nores W.L. Evidence of altered sensitivity of opiate receptors after seizures kindled by picrotoxin. Soc. Neurosci. Abstr. 1993;19:1180. [Google Scholar]
  • 504.Thomas J., Nores W.L., Kenigs V., Olson G.A., Olson R.D. Picrotoxin-induced seizures modified by morphine and opiate antagonists. Pharmacol. Biochem. Behav. 1993;45:615–617. doi: 10.1016/0091-3057(93)90515-u. [DOI] [PubMed] [Google Scholar]
  • 505.Thomas J., Nores W.L., Pariser R. Picrotoxin-induced behavioral tolerance and altered susceptibility to seizures: Effects of naloxone. Pharmacol. Biochem. Behav. 1993;45:619–622. doi: 10.1016/0091-3057(93)90516-v. [DOI] [PubMed] [Google Scholar]
  • 506.Thompson C.I., Margules D.L., Kreider J.W. Propensity to form conditioned taste aversions augments anorexia in obese (ob/ob) mice with B16 melanoma. Behav. Neurosci. 1993;107:786–798. [PubMed] [Google Scholar]
  • 507.Thompson D.L., Weltman J.Y., Rogol A.D., Metzger D.L., Veldhuis J.D., Weltman A. Cholinergic and opioid involvement in release of growth hormone during exercise and recovery. J. Appl. Physiol. 1993;75:870–878. doi: 10.1152/jappl.1993.75.2.870. [DOI] [PubMed] [Google Scholar]
  • 508.Thorat S.J., Bhargava H.N. Blockade of kappa opiate tolerance by MK-801, an NMDA receptor antagonist in the mouse. Soc. Neurosci. Abstr. 1993;19:1025. [Google Scholar]
  • 509.Thorat S.N., Reddy P.L., Bhargava H.N. Evidence for the role of nitric oxide in κ-opiate tolerance in mice. Brain Res. 1993;621:171–174. doi: 10.1016/0006-8993(93)90316-f. [DOI] [PubMed] [Google Scholar]
  • 510.Thorat S.N., Veeranna, Reddy P.L., Bhargava H.N. Biochemical and behavioral studies on the interaction between μ- and κ-opiate agonists in mice. Brain Res. 1993;615:191–198. doi: 10.1016/0006-8993(93)90029-m. [DOI] [PubMed] [Google Scholar]
  • 511.Throsby M., Yang Z., Lee D., Huang W., Copolov D.L., Lim A.T. Coexpression of atrial natriuretic factor and β-endorphin in a subpopulation of rat splenic macrophages: Age-related differences. Endocrinology. 1993;33:2889–2896. doi: 10.1210/endo.133.6.8243316. [DOI] [PubMed] [Google Scholar]
  • 512.Tiseo P.J., Inturrisi C.E. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 1993;264:1090–1096. [PubMed] [Google Scholar]
  • 513.Tomsic D., Massoni V., Maldonado H. Habituation to a danger stimulus in two semiterrestrial crabs: Ontogenic, ecological and opioid modulation correlates. J. Comp. Physiol. [A] 1993:621–633. [Google Scholar]
  • 514.Trouth C.O., Millis R.M., Bernard D.G., Pan Y., Whittaker J.A., Archer P.W. Cholinergic-opioid interactions at brainstem respiratory chemosensitive areas in cats. Neurotoxicology. 1993;14:459–468. [PubMed] [Google Scholar]
  • 515.Trujillo K.A., Akil H. Does MK-801 block naloxone-precipitated opiate withdrawal? Soc. Neurosci. Abstr. 1993;19:1246. [Google Scholar]
  • 516.Tseng L.F., Lin J.J., Collins K.A. Partial antinociceptive cross-tolerance to intracerebroventricular β-endorphin in mice tolerant to systemic morphine. Eur. J. Pharmacol. 1993;241:63–70. doi: 10.1016/0014-2999(93)90933-9. [DOI] [PubMed] [Google Scholar]
  • 517.Tsushima H., Mori M., Matsuda T. Effects of D-Ala2-D-Leu5-enkephalin, microinjected into the supraoptic and paraventricular nuclei, on urine outflow rate. Jpn. J. Pharmacol. 1993;63:181–186. doi: 10.1254/jjp.63.181. [DOI] [PubMed] [Google Scholar]
  • 518.Tsushima H., Mori M., Matsuda T. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release. Jpn. J. Pharmacol. 1993;63:461–468. doi: 10.1254/jjp.63.461. [DOI] [PubMed] [Google Scholar]
  • 519.Uberti E.C.D., Ambrosio M.R., Vergnani L. Stress-induced activation of sympathetic nervous system is attenuated by the γ-opioid receptor agonist deltorphin in healthy man. J. Clin. Endocrinol. Metab. 1993;77:1490–1494. doi: 10.1210/jcem.77.6.8263131. [DOI] [PubMed] [Google Scholar]
  • 520.Ukai M., Itoh J., Kameyama T. Dynorphin A-(1–13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist [D-Ala2,NMePhe4,Gly-ol]enkephalin (DAMGO) in mice. Soc. Neurosci. Abstr. 1993;19:370. [Google Scholar]
  • 521.Ukai M., Kobayashi T., Kameyama T. Dynorphin A-(1–13) attenuates basal forebrain-lesion-induced amnesia in rats. Brain Res. 1993;625:355–356. doi: 10.1016/0006-8993(93)91082-4. [DOI] [PubMed] [Google Scholar]
  • 522.Ukai M., Mori K., Hashimoto S., Kobayashi T., Sasaki Y., Kameyama T. Tyr-D-Arg-Phe-β-Ala-NH2, a novel dermorphin analog, impairs memory consolidation in mice. Eur. J. Pharmacol. 1993;239:237–240. doi: 10.1016/0014-2999(93)91002-5. [DOI] [PubMed] [Google Scholar]
  • 523.Ukai M., Mori E., Kameyama T. Cocaine-like discriminative stimulus properties of the δ-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin, in the rat. Eur. J. Pharmacol. 1993;231:143–144. doi: 10.1016/0014-2999(93)90696-f. [DOI] [PubMed] [Google Scholar]
  • 524.Ukai M., Toyoshi T., Kameyama T. DAMGO ([D-Ala2,NMEPHE4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L-Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse. Neuropharmacology. 1993;32:1019–1024. doi: 10.1016/0028-3908(93)90067-d. [DOI] [PubMed] [Google Scholar]
  • 525.Ukai M., Toyoshi T., Kameyama T. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse. Pharmacol. Biochem. Behav. 1993;46:587–591. doi: 10.1016/0091-3057(93)90548-8. [DOI] [PubMed] [Google Scholar]
  • 526.Vaccarino A.L., Couret L.C., Jr. Formalin-induced pain antagonizes the development of opiate dependence in the rat. Neurosci. Lett. 1993;161:195–198. doi: 10.1016/0304-3940(93)90292-s. [DOI] [PubMed] [Google Scholar]
  • 527.Valentine J.D., Tollison R., Hernandez L.L. Morphine, chlordiazepoxide, and pentobarbital affect appetitive Pavlovian conditioning of motor activity in rats. Soc. Neurosci. Abstr. 1993;19:1026. [Google Scholar]
  • 528.Valeri P., Morrone L.A., Romanelli L., Amico A.C. Effect of nonsteroidal anti-inflammatory drugs on withdrawal responses in guinea pig ileum after a brief exposure to morphine. J. Pharmacol. Exp. Ther. 1993;264:1028–1032. [PubMed] [Google Scholar]
  • 529.Valone J.M., Bardo M.T. Morphine-induced conditioned analgesia using a taste cue in rats. Soc. Neurosci. Abstr. 1993;19:1026. [Google Scholar]
  • 530.Van den Bergh P., Rozing J., Nagelkerken L. β-endorphin stimulates la expression on mouse B cells by inducing interleukin-4 secretion by CD4+ T cells. Cell. Immunol. 1993;149:180–192. doi: 10.1006/cimm.1993.1146. [DOI] [PubMed] [Google Scholar]
  • 531.Van den Bergh P., Rozing J., Nagelkerken L. Identification of two moieties of β-endorphin with opposing effects on rat T-cell proliferation. Immunology. 1993;79:18–23. [PMC free article] [PubMed] [Google Scholar]
  • 532.Vanderah T.W., Wild K.D., Takemori A.E. Modulation of morphine antinociception by swim-stress in the mouse: Involvement of supraspinal opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 1993;267:449–455. [PubMed] [Google Scholar]
  • 533.Vanecek S.A., Young A.M. Evidence for cross-tolerance to the low efficacy agonist, nalbuphine, in pigeons discriminating among two doses of morphine and saline. Soc. Neurosci. Abstr. 1993;19:1180. [Google Scholar]
  • 534.Veeranna, Reddy P., Bhargava H.N. Effect of chronic administration of U-50,488H, a κ-opioid receptor agonist, on central dopamine D2 receptors of the rat. Eur. J. Pharmacol. 1993;235:23–30. doi: 10.1016/0014-2999(93)90815-y. [DOI] [PubMed] [Google Scholar]
  • 535.Vescovi P.P., Michelini M., Maninetti L., Pedrazzoni M., Pioli G., Passeri M. Short time cold exposure and plasma levels of β-endorphin, ACTH, GH, PRL and cortisol in human subjects. Neuroendocrinol. Lett. 1993;15:243–254. [Google Scholar]
  • 536.Vivian J.A., Miczek K.A. Morphine attenuates ultrasonic vocalization during agonistic encounters in adult male rats. Psychopharmacology (Berlin) 1993;111:367–375. doi: 10.1007/BF02244954. [DOI] [PubMed] [Google Scholar]
  • 537.Wagner J.J., Terman G.W., Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature. 1993;363:451–454. doi: 10.1038/363451a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 538.Walker E.A., Young A.M. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J. Pharmacol. Exp. Ther. 1993;267:322–330. [PubMed] [Google Scholar]
  • 539.Walker J.M., Bowen W.D., Patrick S.L., Williams W.E., Mascarella S.W., Bai X., Carroll F.I. A comparison of (−)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of σ2 receptors in motor function. Eur. J. Pharmacol. 1993;231:61–68. doi: 10.1016/0014-2999(93)90684-a. [DOI] [PubMed] [Google Scholar]
  • 540.Wang C., Chakrabarti M.K., Whitwam J.G. Effect of ICI197067, a κ-opioid receptor agonist, spinally on Aδ and C reflexes and intracerebrally on respiration. Eur. J. Pharmacol. 1993;243:113–121. doi: 10.1016/0014-2999(93)90369-s. [DOI] [PubMed] [Google Scholar]
  • 541.Wang J.Q., Ingenito A.J. Comparative effects of intrahippocampal injection of dynorphin A(1–8), dynorphin A(1–13), dynorphin A(1–17), U-50,488H, and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Peptides. 1993;15:125–132. doi: 10.1016/0196-9781(94)90180-5. [DOI] [PubMed] [Google Scholar]
  • 542.Wang Z.P., Man S.Y., Tang F. Age-related changes in the contents of neuropeptides in the rat brain and pituitary. Neurobiol. Aging. 1993;14:529–534. doi: 10.1016/0197-4580(93)90035-a. [DOI] [PubMed] [Google Scholar]
  • 543.Wanke T., Abrahamian H., Lahrmann H. No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes. 1993;42:282–287. doi: 10.2337/diab.42.2.282. [DOI] [PubMed] [Google Scholar]
  • 544.Wanke T., Lahrmann H., Auinger M. Endogenous opioid system during inspiratory loading in patients with type I diabetes. Am. Rev. Respir. Dis. 1993;148:1335–1340. doi: 10.1164/ajrccm/148.5.1335. [DOI] [PubMed] [Google Scholar]
  • 545.Watson G.B., Lanthorn T.H. Electrophysiological actions of delta opioids in CA of the rat hippocampal slice are mediated by one delta receptor subtype. Brain Res. 1993;601:129–135. doi: 10.1016/0006-8993(93)91703-u. [DOI] [PubMed] [Google Scholar]
  • 546.White J.D., Lu X., Camp P. Hypothalamic dynorphin expression during food deprivation. Soc. Neurosci. Abstr. 1993;19:1819. [Google Scholar]
  • 547.Widy-Tyszkiewicz E., Scheel-Kruger J., Christensen A.V. Enhanced disruptive spatial learning effect after sufentanil in renal hypertensive rats versus normotensive rats. Physiol. Behav. 1993;53:467–475. doi: 10.1016/0031-9384(93)90140-b. [DOI] [PubMed] [Google Scholar]
  • 548.Williams C.L., Jensen R.A. Effects of vagotomy on Leu-enkephalin-induced changes in memory storage processes. Physiol. Behav. 1993;54:659–663. doi: 10.1016/0031-9384(93)90073-o. [DOI] [PubMed] [Google Scholar]
  • 549.Wilson S.P. Pertussis toxin enhances proenkephalin synthesis in bovine chromaffin cells. J. Neurochem. 1993;61:1901–1906. doi: 10.1111/j.1471-4159.1993.tb09832.x. [DOI] [PubMed] [Google Scholar]
  • 550.Woodmansee W.W., Silbert L.H., Maier S.F. Factors that modulate inescapable shock-induced reductions in daily activity in the rat. Pharmacol. Biochem. Behav. 1993;45:553–559. doi: 10.1016/0091-3057(93)90505-n. [DOI] [PubMed] [Google Scholar]
  • 551.Woodside B.C., Rochford J. Suckling-induced changes in responsiveness to the hypoalgesia effect of morphine. Soc. Neurosci. Abstr. 1993;19:1787. [Google Scholar]
  • 552.Woolfolk D.R., Holtzman S.G. Restraint stress potentiates analgesia induced by 5′-N-ethylcarboxamidoadenosine: Comparison with morphine. Eur. J. Pharmacol. 1993;239:177–182. doi: 10.1016/0014-2999(93)90991-p. [DOI] [PubMed] [Google Scholar]
  • 553.Yehuda S., Mostofsky D.I. Circadian effects of β-endorphin, melatonin, DSIP, and amphetamine on pentylenetetrazol-induced seizures. Peptides. 1993;14:203–205. doi: 10.1016/0196-9781(93)90030-k. [DOI] [PubMed] [Google Scholar]
  • 554.Yeomans M.R. Prior exposure to low or high fat milk enhances naloxone anorexia in rats. Appetite. 1993;20:125–134. doi: 10.1006/appe.1993.1014. [DOI] [PubMed] [Google Scholar]
  • 555.Yokoyama S. Role of the enteric nervous system in regulating motility of the small intestine: A recollection of my study. Biomed. Res. 1993;14:149–168. [Google Scholar]
  • 556.Yoshie S., Wakasugi C., Kanazawa H., Fujita T. Met-enkephalin-Arg6-Gly7-Leu8-like immunoreactivity in mammalian taste buds. Arch. Histol. Cytol. 1993;56:495–500. doi: 10.1679/aohc.56.495. [DOI] [PubMed] [Google Scholar]
  • 557.Young E.A., Bronstein D., Akil H. Dopamine regulation of swim stress induction of the pituitary intermediate lobe proopiomelanocortin system. Neuroendocrinology. 1993;58:294–302. doi: 10.1159/000126553. [DOI] [PubMed] [Google Scholar]
  • 558.Young E.A., Day R., Schafer M., Watson S.J., Akil H. Altered ratios of beta-endorphin: Beta-lipotropin released from anterior lobe corticotropes with increased secretory drive: II. Repeated stress. J. Neuroendocrinol. 1993;5:12–126. doi: 10.1111/j.1365-2826.1993.tb00371.x. [DOI] [PubMed] [Google Scholar]
  • 559.Young G.A., Hudson G.M., Stamidis H., Steinfels G.F. Interactions between U-50,488H and σ receptor antagonists: EEG, EEG power spectral and behavioral correlates. Eur. J. Pharmacol. 1993;231:473–476. doi: 10.1016/0014-2999(93)90127-4. [DOI] [PubMed] [Google Scholar]
  • 560.Yukhananov R.Y., Zhai Q.Z., Persson S., Post C., Nyberg F. Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens. Neuropharmacology. 1993;32:703–709. doi: 10.1016/0028-3908(93)90084-g. [DOI] [PubMed] [Google Scholar]
  • 561.Zadina J.E., Kastin A.J., Kenigs V., Bruno C., Hackler L. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-GlyNH2) Neurosci. Lett. 1993;55:220–222. doi: 10.1016/0304-3940(93)90712-t. [DOI] [PubMed] [Google Scholar]
  • 562.Zhang C., Bachoo M., Polosa C. The receptors activated by exogenous and endogenous opioids in the superior cervical ganglion of the cat. Brain Res. 1993;622:211–214. doi: 10.1016/0006-8993(93)90821-4. [DOI] [PubMed] [Google Scholar]
  • 563.Zhang C., Bachoo M., Polosa C. Use-dependent fade and two-rate recovery of a naloxone-sensitive inhibition in the cat superior cervical ganglion. Brain Res. 1993;611:279–285. doi: 10.1016/0006-8993(93)90514-n. [DOI] [PubMed] [Google Scholar]
  • 564.Zhang H., Stein E.A. Response properties of ventral tegmental neurons during heroin self-administration in the rat. Soc. Neurosci. Abstr. 1993;19:1023. [Google Scholar]
  • 565.Zhang T., Rockhold R.W. Sucrose drinking reduces dorsal hypothalamic β-endorphin levels in spontaneously hypertensive rats but not in Wistar-Kyoto rats. Brain Res. Bull. 1993;32:26–265. doi: 10.1016/0361-9230(93)90186-f. [DOI] [PubMed] [Google Scholar]
  • 566.Zitnan D., Sauman I., Sehnal F. Peptidergic innervation and endocrine cells in insect midgut. Arch. Insect Biochem. Physiol. 1993;22:113–132. [Google Scholar]

Articles from Peptides are provided here courtesy of Elsevier

RESOURCES